{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T08:14:17Z","timestamp":1779178457776,"version":"3.51.4"},"reference-count":377,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2002,4,1]],"date-time":"2002-04-01T00:00:00Z","timestamp":1017619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,25]],"date-time":"2023-02-25T00:00:00Z","timestamp":1677283200000},"content-version":"vor","delay-in-days":7635,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Clinical Nutrition"],"published-print":{"date-parts":[[2002,4]]},"DOI":"10.1093\/ajcn\/75.4.616","type":"journal-article","created":{"date-parts":[[2018,1,25]],"date-time":"2018-01-25T00:52:29Z","timestamp":1516841549000},"page":"616-658","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":238,"title":["High-dose vitamin therapy stimulates variant enzymes with decreased coenzyme binding affinity (increased Km): relevance to genetic disease and polymorphisms"],"prefix":"10.1016","volume":"75","author":[{"given":"Bruce N","family":"Ames","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilan","family":"Elson-Schwab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eli A","family":"Silver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/ajcn\/75.4.616_bib1","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1056\/NEJM199403103301004","article-title":"X-linked pyridoxine-responsive sideroblastic anemia due to a Thr388\u2013to-Ser substitution in erythroid 5\u2013aminolevulinate synthase","volume":"330","author":"Cox","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1093\/ajcn\/75.4.616_bib2","first-page":"1","article-title":"The natural history of homocystinuria due to cystathionine beta-synthase deficiency","volume":"37","author":"Mudd","year":"1985","journal-title":"Am J Hum Genet"},{"key":"10.1093\/ajcn\/75.4.616_bib3","series-title":"The metabolic and molecular bases of inherited disease.","first-page":"1423","article-title":"Chapter 41. Disorders of propionate and methylmalonate metabolism","author":"Fenton","year":"1995"},{"key":"10.1093\/ajcn\/75.4.616_bib4","series-title":"Mendelian inheritance in man. A catalog of human genes and genetic disorders.","year":"1998"},{"key":"10.1093\/ajcn\/75.4.616_bib5","unstructured":"Elson-Schwab I, Poedjosoedarmo K, Arnes BM. KmMutants.org front page. Internet: http:\/\/www.KmMutants.org (accessed 2 February 2002)."},{"key":"10.1093\/ajcn\/75.4.616_bib6","unstructured":"Swiss Institute of Bioinformatics. ENZYME. Enzyme nomenclature database. Release 27.0, October 2001, updates up to 1 Feb 2002. Internet: http:\/\/www.expasy.ch\/enzyme (accessed 2 February 2002)."},{"key":"10.1093\/ajcn\/75.4.616_bib7","series-title":"Dietary reference intakes for thiamine, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin, and choline.","year":"1998"},{"key":"10.1093\/ajcn\/75.4.616_bib8","series-title":"Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc.","first-page":"126","year":"2001"},{"key":"10.1093\/ajcn\/75.4.616_bib9","series-title":"Recommended dietary allowances.","year":"1989"},{"key":"10.1093\/ajcn\/75.4.616_bib10","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/ajcn\/51.2.225","article-title":"Zinc toxicity","volume":"51","author":"Fosmire","year":"1990","journal-title":"Am J Clin Nutr"},{"key":"10.1093\/ajcn\/75.4.616_bib11","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1073\/pnas.93.8.3704","article-title":"Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance","volume":"93","author":"Levine","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1093\/ajcn\/75.4.616_bib12","doi-asserted-by":"crossref","first-page":"9842","DOI":"10.1073\/pnas.171318198","article-title":"A new recommended dietary allowance of vitamin C for healthy young women","volume":"98","author":"Levine","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1093\/ajcn\/75.4.616_bib13","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1126\/science.160.3825.265","article-title":"Orthomolecular psychiatry. Varying the concentrations of substances normally present in the human body may control mental disease","volume":"160","author":"Pauling","year":"1968","journal-title":"Science"},{"key":"10.1093\/ajcn\/75.4.616_bib14","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1054\/mehy.1999.0955","article-title":"High-dose pyridoxine as an \u2018anti-stress\u2019 strategy","volume":"54","author":"McCarty","year":"2000","journal-title":"Med Hypotheses"},{"key":"10.1093\/ajcn\/75.4.616_bib15","series-title":"Biochemical individuality: the basis for the genetotrophic concept.","author":"Williams","year":"1998"},{"key":"10.1093\/ajcn\/75.4.616_bib16","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1126\/science.1059431","article-title":"Haplotype variation and linkage disequilibrium in 313 human genes","volume":"293","author":"Stephens","year":"2001","journal-title":"Science"},{"key":"10.1093\/ajcn\/75.4.616_bib17","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1073\/pnas.261709098","article-title":"Age-associated mitochondrial oxidative decay: restoration of carnitine acetyltransferase substrate binding affinity and activity in brain by feeding old rats acetyl-l-carnitine and\/or R-\u03b1-lipoic acid","volume":"99","author":"Liu","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1093\/ajcn\/75.4.616_bib18","doi-asserted-by":"crossref","first-page":"10771","DOI":"10.1073\/pnas.91.23.10771","article-title":"Oxidative damage and mitochondrial decay in aging","volume":"91","author":"Shigenaga","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1093\/ajcn\/75.4.616_bib19","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1152\/physrev.1998.78.2.547","article-title":"The free radical theory of aging matures","volume":"78","author":"Beckman","year":"1998","journal-title":"Physiol Rev"},{"key":"10.1093\/ajcn\/75.4.616_bib20","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1073\/pnas.94.7.3064","article-title":"Mitochondrial decay in hepatocytes from old rats: membrane potential declines, heterogeneity and oxidants increase","volume":"94","author":"Hagen","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1093\/ajcn\/75.4.616_bib21","doi-asserted-by":"crossref","first-page":"9562","DOI":"10.1073\/pnas.95.16.9562","article-title":"Acetyl-l-carnitine fed to old rats partially restores mitochondrial function and ambulatory activity","volume":"95","author":"Hagen","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1093\/ajcn\/75.4.616_bib22","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1096\/fasebj.12.12.1183","article-title":"Age-associated decline in ascorbic acid concentration, recycling, and biosynthesis in rat hepatocytes\u2014reversal with (R)-alpha-lipoic acid supplementation","volume":"12","author":"Lykkesfeldt","year":"1998","journal-title":"FASEB J"},{"key":"10.1093\/ajcn\/75.4.616_bib23","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1096\/fasebj.13.2.411","article-title":"(R)-alpha-lipoic acid-supplemented old rats have improved mitochondrial function, decreased oxidative damage, and increased metabolic rate","volume":"13","author":"Hagen","year":"1999","journal-title":"FASEB J"},{"key":"10.1093\/ajcn\/75.4.616_bib24","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1749-6632.1998.tb09904.x","article-title":"Mitochondrial decay in aging. Reversal through supplementation of acetyl-l-carnitine and N-tert-butyl-alpha-phenyl-nitrone","volume":"854","author":"Hagen","year":"1998","journal-title":"Ann N Y Acad Sci"},{"key":"10.1093\/ajcn\/75.4.616_bib25","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1073\/pnas.261708898","article-title":"Feeding acetyl-l-carnitine and lipoic acid to old rats significantly improves metabolic function while decreasing oxidative stress","volume":"99","author":"Hagen","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1093\/ajcn\/75.4.616_bib26","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1073\/pnas.261709299","article-title":"Memory loss in old rats is associated with brain mitochondrial decay and RNA\/DNA oxidation: partial reversal by feeding acetyl-l-carnitine and\/or R-\u03b1-lipoic acid","volume":"99","author":"Liu","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1093\/ajcn\/75.4.616_bib27","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1128\/jb.108.1.359-363.1971","article-title":"Salmonella typhimurium mutants with alternate requirements for vitamin B6 or isoleucine","volume":"108","author":"Guirard","year":"1971","journal-title":"J Bacteriol"},{"key":"10.1093\/ajcn\/75.4.616_bib28","doi-asserted-by":"crossref","first-page":"19350","DOI":"10.1074\/jbc.M100029200","article-title":"Pyridoxal phosphate binding sites are similar in human heme-dependent and yeast heme-independent cystathionine beta-synthases. Evidence from 31P NMR and pulsed EPR spectroscopy that heme and PLP cofactors are not proximal in the human enzyme","volume":"276","author":"Kabil","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1093\/ajcn\/75.4.616_bib29","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1073\/pnas.97.3.1224","article-title":"Correction of ornithine accumulation prevents retinal degeneration in a mouse model of gyrate atrophy of the choroid and retina","volume":"97","author":"Wang","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1093\/ajcn\/75.4.616_bib30","first-page":"616","article-title":"Pyridoxine-responsive gyrate atrophy of the choroid and retina: clinical and biochemical correlates of the mutation A226V","volume":"56","author":"Michaud","year":"1995","journal-title":"Am J Hum Genet"},{"key":"10.1093\/ajcn\/75.4.616_bib31","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1073\/pnas.85.11.3777","article-title":"Molecular basis of ornithine aminotransferase deficiency in B-6\u2013responsive and -nonresponsive forms of gyrate atrophy","volume":"85","author":"Ramesh","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1093\/ajcn\/75.4.616_bib32","first-page":"929","article-title":"Pyridoxine effects on ornithine ketoacid transaminase activity in fibroblasts from carriers of two forms of gyrate atrophy of the choroid and retina","volume":"43","author":"Shih","year":"1988","journal-title":"Am J Hum Genet"},{"key":"10.1093\/ajcn\/75.4.616_bib33","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S0140-6736(78)92211-0","article-title":"Vitamin B6 in management of gyrate atrophy of choroid and retina","volume":"2","author":"Weleber","year":"1978","journal-title":"Lancet"},{"key":"10.1093\/ajcn\/75.4.616_bib34","first-page":"344","article-title":"Gyrate atrophy of the choroid and retina: characterization of mutant ornithine aminotransferase and mechanism of response to vitamin B6","volume":"44","author":"Kennaway","year":"1989","journal-title":"Am J Hum Genet"},{"key":"10.1093\/ajcn\/75.4.616_bib35","doi-asserted-by":"crossref","first-page":"792","DOI":"10.3109\/02713689609003464","article-title":"Heterogeneity and uniqueness of ornithine aminotransferase mutations found in Japanese gyrate atrophy patients","volume":"15","author":"Mashima","year":"1996","journal-title":"Curr Eye Res"},{"key":"10.1093\/ajcn\/75.4.616_bib36","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1136\/bjo.65.7.478","article-title":"Gyrate atrophy with hyperornithinaemia: different types of responsiveness to vitamin B6","volume":"65","author":"Hayasaka","year":"1981","journal-title":"Br J Ophthalmol"},{"key":"10.1093\/ajcn\/75.4.616_bib37","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF02263591","article-title":"Hyperornithinaemia associated with gyrate atrophy of the choroid and retina: in vivo and in vitro response to vitamin B6","volume":"4","author":"Tada","year":"1981","journal-title":"J Inherit Metab Dis"},{"key":"10.1093\/ajcn\/75.4.616_bib38","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1076\/opge.20.4.219.2271","article-title":"Genotype-phenotype correlation of a pyridoxine-responsive form of gyrate atrophy","volume":"20","author":"Mashima","year":"1999","journal-title":"Ophthalmic Genet"},{"key":"10.1093\/ajcn\/75.4.616_bib39","series-title":"The metabolic and molecular bases of inherited disease.","first-page":"1147","article-title":"Chapter 31. The hyperornithinemias","author":"Valle","year":"1995"},{"key":"10.1093\/ajcn\/75.4.616_bib40","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0022-3476(69)80274-X","article-title":"The successful treatment of homocystinuria with pyridoxine","volume":"75","author":"Barber","year":"1969","journal-title":"J Pediatr"},{"key":"10.1093\/ajcn\/75.4.616_bib41","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1073\/pnas.71.12.4821","article-title":"On the mechanism of pyridoxine responsive homocystinuria. II. Properties of normal and mutant cystathionine beta-synthase from cultured fibroblasts","volume":"71","author":"Kim","year":"1974","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1093\/ajcn\/75.4.616_bib42","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1172\/JCI109843","article-title":"Affinity of cystathionine beta-synthase for pyridoxal 5\u2032-phosphate in cultured cells. A mechanism for pyridoxine-responsive homocystinuria","volume":"66","author":"Lipson","year":"1980","journal-title":"J Clin Invest"},{"key":"10.1093\/ajcn\/75.4.616_bib43","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/hmg\/2.6.815","article-title":"Molecular defect in a patient with pyridoxine-responsive homocystinuria","volume":"2","author":"Kozich","year":"1993","journal-title":"Hum Mol Genet"},{"key":"10.1093\/ajcn\/75.4.616_bib44","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1093\/hmg\/6.13.2213","article-title":"Functional modeling of vitamin responsiveness in yeast: a common pyridoxine-responsive cystathionine beta-synthase mutation in homocystinuria","volume":"6","author":"Kim","year":"1997","journal-title":"Hum Mol Genet"},{"key":"10.1093\/ajcn\/75.4.616_bib45","first-page":"34","article-title":"A missense mutation (I278T) in the cystathionine beta-synthase gene prevalent in pyridoxine-responsive homocystinuria and associated with mild clinical phenotype","volume":"57","author":"Shih","year":"1995","journal-title":"Am J Hum Genet"},{"key":"10.1093\/ajcn\/75.4.616_bib46","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/BF01800664","article-title":"Recent advances in the mechanism of pyridoxine-responsive disorders","volume":"8","author":"Fowler","year":"1985","journal-title":"J Inherit Metab Dis"},{"key":"10.1093\/ajcn\/75.4.616_bib47","series-title":"The metabolic and molecular bases of inherited disease.","first-page":"1279","article-title":"Chapter 35. Disorders of transsulfuration","author":"Mudd","year":"1995"},{"key":"10.1093\/ajcn\/75.4.616_bib48","unstructured":"Kraus JP. Cystathionine \u03b2-synthase main page. Version current 6 March 2001. Internet: http:\/\/www.uchsc.edu\/sm\/cbs\/cbsdata\/cbsmain.htm (accessed 2 February 2002)."},{"key":"10.1093\/ajcn\/75.4.616_bib49","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/ana.410440219","article-title":"Beneficial effects of l-serine and glycine in the management of seizures in 3-phosphoglycerate dehydrogenase deficiency","volume":"44","author":"de Koning","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1093\/ajcn\/75.4.616_bib50","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1055\/s-2001-17373","article-title":"Phenotypic heterogeneity and adverse effects of serine treatment in 3-phosphoglycerate dehydrogenase deficiency: report on two siblings","volume":"32","author":"Hausler","year":"2001","journal-title":"Neuropediatrics"},{"key":"10.1093\/ajcn\/75.4.616_bib51","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1056\/NEJM199104253241701","article-title":"Hyperhomocysteinemia: an independent risk factor for vascular disease","volume":"324","author":"Clarke","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1093\/ajcn\/75.4.616_bib52","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1161\/01.ATV.17.5.989","article-title":"Plasma total homocysteine, B vitamins, and risk of coronary atherosclerosis","volume":"17","author":"Verhoef","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1093\/ajcn\/75.4.616_bib53","first-page":"56","article-title":"The molecular biology and pyridoxine responsiveness of X-linked sideroblastic anaemia","volume":"83","author":"May","year":"1998","journal-title":"Haematologica"},{"key":"10.1093\/ajcn\/75.4.616_bib54","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1182\/blood.V84.11.3915.bloodjournal84113915","article-title":"X-linked sideroblastic anemia: identification of the mutation in the erythroid-specific delta-aminolevulinate synthase gene (ALAS2) in the original family described by Cooley","volume":"84","author":"Cotter","year":"1994","journal-title":"Blood"},{"key":"10.1093\/ajcn\/75.4.616_bib55","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/(SICI)1096-8652(199910)62:2<112::AID-AJH9>3.0.CO;2-L","article-title":"A novel mutation of the erythroid-specific delta-aminolevulinate synthase gene in a patient with non-inherited pyridoxine-responsive sideroblastic anemia","volume":"62","author":"Harigae","year":"1999","journal-title":"Am J Hematol"},{"key":"10.1093\/ajcn\/75.4.616_bib56","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1073\/pnas.89.9.4028","article-title":"Enzymatic defect in \u201cX-linked\u201d sideroblastic anemia: molecular evidence for erythroid delta-aminolevulinate synthase deficiency","volume":"89","author":"Cotter","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1093\/ajcn\/75.4.616_bib57","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/BF00208968","article-title":"A new mutation of the ALAS2 gene in a large family with X-linked sideroblastic anemia","volume":"95","author":"Prades","year":"1995","journal-title":"Hum Genet"},{"key":"10.1093\/ajcn\/75.4.616_bib58","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1172\/JCI118258","article-title":"Late-onset X-linked sideroblastic anemia. Missense mutations in the erythroid delta-aminolevulinate synthase (ALAS2) gene in two pyridoxine-responsive patients initially diagnosed with acquired refractory anemia and ringed sideroblasts","volume":"96","author":"Cotter","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1093\/ajcn\/75.4.616_bib59","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1182\/blood.V93.5.1757","article-title":"Four new mutations in the erythroid-specific 5-aminolevulinate synthase ALAS2 gene causing X-linked sideroblastic anemia: increased pyridoxine responsiveness after removal of iron overload by phlebotomy and coinheritance of hereditary hemochromatosis","volume":"93","author":"Cotter","year":"1999","journal-title":"Blood"},{"key":"10.1093\/ajcn\/75.4.616_bib60","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1046\/j.1365-2141.1998.01050.x","article-title":"R411C mutation of the ALAS2 gene encodes a pyridoxine-responsive enzyme with low activity","volume":"103","author":"Furuyama","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1093\/ajcn\/75.4.616_bib61","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1046\/j.1365-2141.1999.01479.x","article-title":"A novel mutation of the erythroid-specific delta-aminolaevulinate synthase gene in a patient with X-linked sideroblastic anaemia","volume":"106","author":"Harigae","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1093\/ajcn\/75.4.616_bib62","doi-asserted-by":"crossref","first-page":"14109","DOI":"10.1021\/bi961296h","article-title":"Mutations at a glycine loop in aminolevulinate synthase affect pyridoxal phosphate cofactor binding and catalysis","volume":"35","author":"Gong","year":"1996","journal-title":"Biochemistry"},{"key":"10.1093\/ajcn\/75.4.616_bib63","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1620\/tjem.93.115","article-title":"Vitamin B6 dependent xanthurenic aciduria","volume":"93","author":"Tada","year":"1967","journal-title":"Tohoku J Exp Med"},{"key":"10.1093\/ajcn\/75.4.616_bib64","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1620\/tjem.95.107","article-title":"Vitamin B6 dependent xanthurenic aciduria (the second report)","volume":"95","author":"Tada","year":"1968","journal-title":"Tohoku J Exp Med"},{"key":"10.1093\/ajcn\/75.4.616_bib65","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0022-3476(98)70384-1","article-title":"Current perspectives on pyridoxine-dependent seizures","volume":"132","author":"Gospe","year":"1998","journal-title":"J Pediatr"},{"key":"10.1093\/ajcn\/75.4.616_bib66","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1469-8749.1997.tb08206.x","article-title":"Pyridoxine dependency: an update","volume":"39","author":"Gordon","year":"1997","journal-title":"Dev Med Child Neurol"},{"key":"10.1093\/ajcn\/75.4.616_bib67","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0140-6736(94)90236-4","article-title":"Reduced GABA synthesis in pyridoxine-dependent seizures","volume":"343","author":"Gospe","year":"1994","journal-title":"Lancet"},{"issue":"suppl","key":"10.1093\/ajcn\/75.4.616_bib68","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1528-1157.1998.tb05149.x","article-title":"ACTH therapy for infantile spasms: a combination therapy with high-dose pyridoxal phosphate and low-dose ACTH","volume":"39","author":"Takuma","year":"1998","journal-title":"Epilepsia"},{"key":"10.1093\/ajcn\/75.4.616_bib69","first-page":"121","article-title":"Pyridoxine dependent seizures","volume":"33","author":"Singh","year":"1996","journal-title":"Indian Pediatr"},{"key":"10.1093\/ajcn\/75.4.616_bib70","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1212\/WNL.28.1.47","article-title":"Vitamin B6-dependent seizures: pathology and chemical findings in brain","volume":"28","author":"Lott","year":"1978","journal-title":"Neurology"},{"key":"10.1093\/ajcn\/75.4.616_bib71","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1620\/tjem.104.195","article-title":"Vitamin B6-dependency of glutamic acid decarboxylase in the kidney from a patient with vitamin B6 dependent convulsion","volume":"104","author":"Yoshida","year":"1971","journal-title":"Tohoku J Exp Med"},{"key":"10.1093\/ajcn\/75.4.616_bib72","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1111\/j.1469-8749.1996.tb15060.x","article-title":"Pyridoxine-dependent seizures: demographic, clinical, MRI and psychometric features, and effect of dose on intelligence quotient","volume":"38","author":"Baxter","year":"1996","journal-title":"Dev Med Child Neurol"},{"key":"10.1093\/ajcn\/75.4.616_bib73","first-page":"342","article-title":"Pyridoxine as therapy in theophylline-induced seizures","volume":"37","author":"Glenn","year":"1995","journal-title":"Vet Hum Toxicol"},{"key":"10.1093\/ajcn\/75.4.616_bib74","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s100380050053","article-title":"Mutation and polymorphic marker analyses of 65K-and 67K-glutamate decarboxylase genes in two families with pyridoxine-dependent epilepsy","volume":"43","author":"Kure","year":"1998","journal-title":"J Hum Genet"},{"key":"10.1093\/ajcn\/75.4.616_bib75","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0387-7604(00)00193-5","article-title":"CSF glutamate\/GABA concentrations in pyridoxine-dependent seizures: etiology of pyridoxine-dependent seizures and the mechanisms of pyridoxine action in seizure control","volume":"23","author":"Goto","year":"2001","journal-title":"Brain Dev"},{"key":"10.1093\/ajcn\/75.4.616_bib76","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1126\/science.149.3688.1095","article-title":"Cystathioninuria: nature of the defect","volume":"149","author":"Frimpter","year":"1965","journal-title":"Science"},{"key":"10.1093\/ajcn\/75.4.616_bib77","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1126\/science.1198108","article-title":"Vitamin B6\u2013responsive and -unresponsive cystathioninuria: two variant molecular forms","volume":"190","author":"Pascal","year":"1975","journal-title":"Science"},{"key":"10.1093\/ajcn\/75.4.616_bib78","first-page":"565","article-title":"The action of pyridoxine in primary hyperoxaluria","volume":"37","author":"Gibbs","year":"1969","journal-title":"Clin Sci"},{"key":"10.1093\/ajcn\/75.4.616_bib79","series-title":"The metabolic and molecular bases of inherited disease.","first-page":"2385","article-title":"Chapter 75. Primary hyperoxaluria","author":"Danpure","year":"1995"},{"key":"10.1093\/ajcn\/75.4.616_bib80","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1056\/NEJM199412083312304","article-title":"Results of long-term treatment with orthophosphate and pyridoxine in patients with primary hyperoxaluria","volume":"331","author":"Milliner","year":"1994","journal-title":"N Engl J Med"},{"issue":"suppl","key":"10.1093\/ajcn\/75.4.616_bib81","first-page":"49","article-title":"Pyridoxine-responsive PH1: treatment","volume":"11","author":"Toussaint","year":"1998","journal-title":"J Nephrol"},{"key":"10.1093\/ajcn\/75.4.616_bib82","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1073\/pnas.69.2.343","article-title":"On the identity of DOPA decarboxylase and 5-hydroxytryptophan decarboxylase (immunological titration-aromatic l-amino acid decarboxylase-serotonin-dopamine-norepinephrine)","volume":"69","author":"Christenson","year":"1972","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1093\/ajcn\/75.4.616_bib83","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1212\/WNL.42.10.1980","article-title":"Aromatic l-amino acid decarboxylase deficiency: clinical features, diagnosis, and treatment of a new inborn error of neurotransmitter amine synthesis","volume":"42","author":"Hyland","year":"1992","journal-title":"Neurology"},{"key":"10.1093\/ajcn\/75.4.616_bib84","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1177\/088307389701200602","article-title":"Aromatic l-amino acid decarboxylase deficiency: clinical features, diagnosis, and treatment of a second family","volume":"12","author":"Maller","year":"1997","journal-title":"J Child Neurol"},{"key":"10.1093\/ajcn\/75.4.616_bib85","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/ajh\/6.1.33","article-title":"Defective 3,4-dihydroxyphenylalanine decarboxylation to dopamine in hydralazine-treated hypertensive patients may be pyridoxine remediable","volume":"6","author":"Shigetomi","year":"1993","journal-title":"Am J Hypertens"},{"key":"10.1093\/ajcn\/75.4.616_bib86","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0888-7543(90)90542-3","article-title":"Human delta-aminolevulinate synthase: assignment of the housekeeping gene to 3p21 and the erythroid-specific gene to the X chromosome","volume":"7","author":"Bishop","year":"1990","journal-title":"Genomics"},{"key":"10.1093\/ajcn\/75.4.616_bib87","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2141.1979.tb03699.x","article-title":"Haem synthesis in sideroblastic anaemia","volume":"42","author":"Konopka","year":"1979","journal-title":"Br J Haematol"},{"key":"10.1093\/ajcn\/75.4.616_bib88","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1600-0609.1982.tb00617.x","article-title":"Pyridoxine-responsive primary acquired sideroblastic anaemia. In vitro and in vivo effects of vitamin B6 on decreased 5-aminolaevulinate synthase activity","volume":"29","author":"Meier","year":"1982","journal-title":"Scand J Haematol"},{"key":"10.1093\/ajcn\/75.4.616_bib89","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1212\/WNL.44.9.1728","article-title":"Pyridoxine-responsive hyper-beta-alaninemia associated with Cohen\u2019s syndrome","volume":"44","author":"Higgins","year":"1994","journal-title":"Neurology"},{"key":"10.1093\/ajcn\/75.4.616_bib90","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1054\/mehy.1999.0999","article-title":"Is autism a G-alpha protein defect reversible with natural vitamin A?","volume":"54","author":"Megson","year":"2000","journal-title":"Med Hypotheses"},{"key":"10.1093\/ajcn\/75.4.616_bib91","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2165\/00128072-200002010-00006","article-title":"Autism: current theories regarding its pathogenesis and implications for rational pharmacotherapy","volume":"2","author":"Buitelaar","year":"2000","journal-title":"Paediatr Drugs"},{"key":"10.1093\/ajcn\/75.4.616_bib92","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/BF02178295","article-title":"Efficacy of vitamin B6 and magnesium in the treatment of autism: a methodology review and summary of outcomes","volume":"25","author":"Pfeiffer","year":"1995","journal-title":"J Autism Dev Disord"},{"issue":"suppl","key":"10.1093\/ajcn\/75.4.616_bib93","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1177\/0883073888003001S13","article-title":"Controversies in the treatment of autistic children: vitamin and drug therapy","volume":"3","author":"Rimland","year":"1988","journal-title":"J Child Neurol"},{"key":"10.1093\/ajcn\/75.4.616_bib94","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1176\/ajp.135.4.472","article-title":"The effect of high doses of vitamin B6 on autistic children: a double-blind crossover study","volume":"135","author":"Rimland","year":"1978","journal-title":"Am J Psychiatry"},{"key":"10.1093\/ajcn\/75.4.616_bib95","first-page":"437","article-title":"The effect of pyridoxine hydrochloride on blood serotonin and pyridoxal phosphate contents in hyperactive children","volume":"55","author":"Bhagavan","year":"1975","journal-title":"Pediatrics"},{"key":"10.1093\/ajcn\/75.4.616_bib96","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0006-3223(85)90019-8","article-title":"Vitamin B6, magnesium, and combined B6-Mg: therapeutic effects in childhood autism","volume":"20","author":"Martineau","year":"1985","journal-title":"Biol Psychiatry"},{"key":"10.1093\/ajcn\/75.4.616_bib97","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/j.1469-8749.1966.tb01830.x","article-title":"A study of tryptophan metabolism in psychotic children","volume":"8","author":"Heeley","year":"1966","journal-title":"Dev Med Child Neurol"},{"key":"10.1093\/ajcn\/75.4.616_bib98","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/0006-3223(91)90060-Y","article-title":"Niacin and vitamin B6 in mental functioning: a review of controlled trials in humans","volume":"29","author":"Kleijnen","year":"1991","journal-title":"Biol Psychiatry"},{"key":"10.1093\/ajcn\/75.4.616_bib99","first-page":"308","article-title":"Experiences with pyrithioxin in brain-damaged children with autistic syndrome","volume":"17","author":"Bonisch","year":"1968","journal-title":"Prax Kinderpsychol Kinderpsychiatr"},{"key":"10.1093\/ajcn\/75.4.616_bib100","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF01531686","article-title":"Effects of pyridoxine and magnesium on autistic symptoms\u2014initial observations","volume":"11","author":"Lelord","year":"1981","journal-title":"J Autism Dev Disord"},{"key":"10.1093\/ajcn\/75.4.616_bib101","first-page":"661","article-title":"Clinical and biochemical value of Magnesium + vitamin B6 combination in the treatment of residual autism in adults","volume":"39","author":"Jonas","year":"1984","journal-title":"Therapie"},{"key":"10.1093\/ajcn\/75.4.616_bib102","first-page":"627","article-title":"Effects of vitamin B6 on averaged evoked potentials in infantile autism","volume":"16","author":"Martineau","year":"1981","journal-title":"Biol Psychiatry"},{"key":"10.1093\/ajcn\/75.4.616_bib103","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1023\/A:1026000901515","article-title":"Critique of \u201cEfficacy of vitamin B6 and magnesium in the treatment of autism.\u201d","volume":"28","author":"Rimland","year":"1998","journal-title":"J Autism Dev Disord"},{"key":"10.1093\/ajcn\/75.4.616_bib104","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1469-8749.1997.tb07437.x","article-title":"Possible effects of tetrahydrobiopterin treatment in six children with autism\u2014clinical and positron emission tomography data: a pilot study","volume":"39","author":"Fernell","year":"1997","journal-title":"Dev Med Child Neurol"},{"key":"10.1093\/ajcn\/75.4.616_bib105","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1176\/appi.ajp.158.9.1511","article-title":"Vitamin B6 in the treatment of tardive dyskinesia: a double-blind, placebo-controlled, crossover study","volume":"158","author":"Lerner","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1093\/ajcn\/75.4.616_bib106","first-page":"241","article-title":"Vitamin B6 in treatment of tardive dyskinesia: a preliminary case series study","volume":"22","author":"Lerner","year":"1999","journal-title":"Clin Neuropharmacol"},{"key":"10.1093\/ajcn\/75.4.616_bib107","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1017\/S1461145700001796","article-title":"Homozygosity for the Gly-9 variant of the dopamine D3 receptor and risk for tardive dyskinesia in schizophrenic patients","volume":"3","author":"Lovlie","year":"2000","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1093\/ajcn\/75.4.616_bib108","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000054924","article-title":"Association between the Ser9Gly polymorphism of the dopamine D3 receptor gene and tardive dyskinesia in Chinese schizophrenic patients","volume":"44","author":"Liao","year":"2001","journal-title":"Neuropsychobiology"},{"key":"10.1093\/ajcn\/75.4.616_bib109","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/jn\/108.4.545","article-title":"Validation of the diagnostic value of plasma pyridoxal 5\u2032-phosphate measurements in vitamin B6 nutrition of the rat","volume":"108","author":"Lumeng","year":"1978","journal-title":"J Nutr"},{"key":"10.1093\/ajcn\/75.4.616_bib110","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/hep.1840060324","article-title":"The fasting B6 vitamer profile and response to a pyridoxine load in normal and cirrhotic subjects","volume":"6","author":"Henderson","year":"1986","journal-title":"Hepatology"},{"key":"10.1093\/ajcn\/75.4.616_bib111","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0969-2126(00)00105-2","article-title":"Crystal structure of human branched-chain alpha-ketoacid dehydrogenase and the molecular basis of multienzyme complex deficiency in maple syrup urine disease","volume":"8","author":"Evarsson","year":"2000","journal-title":"Structure Fold Des"},{"key":"10.1093\/ajcn\/75.4.616_bib112","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/BF01800663","article-title":"Thiamine-responsive inborn errors of metabolism","volume":"8","author":"Duran","year":"1985","journal-title":"J Inherit Metab Dis"},{"key":"10.1093\/ajcn\/75.4.616_bib113","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S0140-6736(71)91041-5","article-title":"Thiamine-responsive maple-syrup-urine disease","volume":"1","author":"Scriver","year":"1971","journal-title":"Lancet"},{"key":"10.1093\/ajcn\/75.4.616_bib114","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1073\/pnas.79.10.3300","article-title":"Thiamin-responsive maple-syrup-urine disease: decreased affinity of the mutant branched-chain alpha-keto acid dehydrogenase for alpha-ketoisovalerate and thiamin pyrophosphate","volume":"79","author":"Chuang","year":"1982","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1093\/ajcn\/75.4.616_bib115","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1016\/S0021-9258(18)94087-1","article-title":"Molecular phenotypes in cultured maple syrup urine disease cells. Complete E1 alpha cDNA sequence and mRNA and subunit contents of the human branched chain alpha-keto acid dehydrogenase complex","volume":"264","author":"Fisher","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1093\/ajcn\/75.4.616_bib116","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/0006-291X(91)91489-Y","article-title":"A 17-bp insertion and a Phe215\u2192Cys missense mutation in the dihydrolipoyl transacylase (E2) mRNA from a thiamine-responsive maple syrup urine disease patient WG-34","volume":"174","author":"Fisher","year":"1991","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1093\/ajcn\/75.4.616_bib117","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/0925-4439(92)90043-M","article-title":"Branched chain acyltransferase absence due to an Alu-based genomic deletion allele and an exon skipping allele in a compound heterozygote proband expressing maple syrup urine disease","volume":"1138","author":"Herring","year":"1992","journal-title":"Biochim Biophys Acta"},{"key":"10.1093\/ajcn\/75.4.616_bib118","first-page":"843","article-title":"Sequence of the E1 alpha subunit of branched-chain alpha-ketoacid dehydrogenase in two patients with thiamine-responsive maple syrup urine disease","volume":"46","author":"Zhang","year":"1990","journal-title":"Am J Hum Genet"},{"key":"10.1093\/ajcn\/75.4.616_bib119","series-title":"The metabolic and molecular bases of inherited disease.","first-page":"1239","article-title":"Chapter 34. Disorders of branched chain amino acids and keto acid metabolism","author":"Chuang","year":"1995"},{"key":"10.1093\/ajcn\/75.4.616_bib120","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1749-6632.1982.tb31214.x","article-title":"The role of thiamin in maple syrup urine disease","volume":"378","author":"Elsas","year":"1982","journal-title":"Ann N Y Acad Sci"},{"key":"10.1093\/ajcn\/75.4.616_bib121","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/S0022-3476(98)70523-2","article-title":"Maple syrup urine disease: it has come a long way","volume":"132","author":"Chuang","year":"1998","journal-title":"J Pediatr"},{"key":"10.1093\/ajcn\/75.4.616_bib122","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1136\/bjo.83.2.250","article-title":"A case of reversible blindness in maple syrup urine disease","volume":"83","author":"Backhouse","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"10.1093\/ajcn\/75.4.616_bib123","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/0003-9861(88)90252-4","article-title":"Monovalent cations and inorganic phosphate alter branched-chain alpha-ketoacid dehydrogenase-kinase activity and inhibitor sensitivity","volume":"266","author":"Shimomura","year":"1988","journal-title":"Arch Biochem Biophys"},{"key":"10.1093\/ajcn\/75.4.616_bib124","doi-asserted-by":"crossref","first-page":"10395","DOI":"10.1074\/jbc.274.15.10395","article-title":"GroEL\/GroES-dependent reconstitution of alpha2 beta2 tetramers of human mitochondrial branched chain alpha-ketoacid decarboxylase. Obligatory interaction of chaperonins with an alpha beta dimeric intermediate","volume":"274","author":"Chuang","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1093\/ajcn\/75.4.616_bib125","series-title":"The metabolic and molecular bases of inherited disease.","first-page":"1479","article-title":"Chapter 44. Lactic acidemia (disorders of pyruvate carboxylase, pyruvate dehydrogenase)","author":"Robinson","year":"1995"},{"key":"10.1093\/ajcn\/75.4.616_bib126","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/BF00466274","article-title":"Hyperalaninemia, hyperpyruvicemia and lactic acidosis due to pyruvate carboxylase deficiency of the liver; treatment with thiamine and lipoic acid","volume":"122","author":"Maesaka","year":"1976","journal-title":"Eur J Pediatr"},{"key":"10.1093\/ajcn\/75.4.616_bib127","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1203\/00006450-199409000-00013","article-title":"Molecular analysis of abnormal pyruvate dehydrogenase in a patient with thiamine-responsive congenital lactic acidemia","volume":"36","author":"Naito","year":"1994","journal-title":"Pediatr Res"},{"key":"10.1093\/ajcn\/75.4.616_bib128","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3177\/jnsv.38.Special_585","article-title":"Thiamine responsive pyruvate dehydrogenase deficiency","author":"Narisawa","year":"1992","journal-title":"J Nutr Sci Vitaminol (Tokyo)"},{"key":"10.1093\/ajcn\/75.4.616_bib129","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/BF02435969","article-title":"Vitamin-responsive pyruvate dehydrogenase deficiency in a young girl with external ophthalmoplegia, myopathy and lactic acidosis","volume":"15","author":"Scholte","year":"1992","journal-title":"J Inherit Metab Dis"},{"key":"10.1093\/ajcn\/75.4.616_bib130","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/BF01969575","article-title":"Thiamine dependency in a patient with congenital lacticacidaemia due to pyruvate dehydrogenase deficiency","volume":"7","author":"Wick","year":"1977","journal-title":"Agents Actions"},{"key":"10.1093\/ajcn\/75.4.616_bib131","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1007\/s004310050903","article-title":"Thiamine-responsive lactic acidaemia: role of pyruvate dehydrogenase complex","volume":"157","author":"Naito","year":"1998","journal-title":"Eur J Pediatr"},{"key":"10.1093\/ajcn\/75.4.616_bib132","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/0387-7604(94)00103-5","article-title":"Thiamine responsive congenital lactic acidemia and type 1 muscle fiber atrophy","volume":"17","author":"Murakami","year":"1995","journal-title":"Brain Dev"},{"key":"10.1093\/ajcn\/75.4.616_bib133","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0022-510X(99)00250-6","article-title":"Concomitant administration of sodium dichloroacetate and thiamine in West syndrome caused by thiamine-responsive pyruvate dehydrogenase complex deficiency","volume":"171","author":"Naito","year":"1999","journal-title":"J Neurol Sci"},{"key":"10.1093\/ajcn\/75.4.616_bib134","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0887-8994(00)00185-5","article-title":"Long-term follow-up of vitamin B(6)-responsive West syndrome","volume":"23","author":"Ohtsuka","year":"2000","journal-title":"Pediatr Neurol"},{"key":"10.1093\/ajcn\/75.4.616_bib135","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1006\/abbi.1999.1231","article-title":"Characterization of point mutations in patients with pyruvate dehydrogenase deficiency: role of methionine-181, proline-188, and arginine-349 in the alpha subunit","volume":"367","author":"Tripatara","year":"1999","journal-title":"Arch Biochem Biophys"},{"key":"10.1093\/ajcn\/75.4.616_bib136","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/10372","article-title":"Mutations in SLC19A2 cause thiamine-responsive megaloblastic anaemia associated with diabetes mellitus and deafness","volume":"22","author":"Labay","year":"1999","journal-title":"Nat Genet"},{"key":"10.1093\/ajcn\/75.4.616_bib137","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/10385","article-title":"Mutations in a new gene encoding a thiamine transporter cause thiamine-responsive megaloblastic anaemia syndrome","volume":"22","author":"Diaz","year":"1999","journal-title":"Nat Genet"},{"key":"10.1093\/ajcn\/75.4.616_bib138","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0022-3476(89)80558-X","article-title":"Thiamine-responsive anemia in DIDMOAD syndrome","volume":"114","author":"Borgna-Pignatti","year":"1989","journal-title":"J Pediatr"},{"key":"10.1093\/ajcn\/75.4.616_bib139","first-page":"543","article-title":"Thiamine responsive anemia: report of a new case associated with a thiamine pyrophosphokinase deficiency","volume":"33","author":"Grill","year":"1991","journal-title":"Nouv Rev Fr Hematol"},{"key":"10.1093\/ajcn\/75.4.616_bib140","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1023\/A:1005302717117","article-title":"Muscle biochemistry in thiamin-responsive anaemia","volume":"20","author":"Barrett","year":"1997","journal-title":"J Inherit Metab Dis"},{"key":"10.1093\/ajcn\/75.4.616_bib141","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0022-3476(85)80011-1","article-title":"Diabetes mellitus, thiamine-dependent megaloblastic anemia, and sensorineural deafness associated with deficient alpha-ketoglutarate dehydrogenase activity","volume":"107","author":"Abboud","year":"1985","journal-title":"J Pediatr"},{"key":"10.1093\/ajcn\/75.4.616_bib142","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S0022-3476(69)80031-4","article-title":"Thiamine-responsive megaloblastic anemia","volume":"74","author":"Rogers","year":"1969","journal-title":"J Pediatr"},{"key":"10.1093\/ajcn\/75.4.616_bib143","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/BF00712009","article-title":"Further studies on erythrocyte thiamin transport and phosphorylation in seven patients with thiamin-responsive megaloblastic anaemia","volume":"17","author":"Rindi","year":"1994","journal-title":"J Inherit Metab Dis"},{"key":"10.1093\/ajcn\/75.4.616_bib144","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0925-4439(01)00073-4","article-title":"SLC19A3 encodes a second thiamine transporter ThTr2","volume":"1537","author":"Rajgopal","year":"2001","journal-title":"Biochim Biophys Acta"},{"key":"10.1093\/ajcn\/75.4.616_bib145","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF01804393","article-title":"Neonatal cardiomyopathy and lactic acidosis responsive to thiamine","volume":"14","author":"Bakker","year":"1991","journal-title":"J Inherit Metab Dis"},{"key":"10.1093\/ajcn\/75.4.616_bib146","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S0140-6736(96)10338-X","article-title":"A 6-month-old girl with cardiomyopathy who nearly died","volume":"349","author":"Di Rocco","year":"1997","journal-title":"Lancet"},{"key":"10.1093\/ajcn\/75.4.616_bib147","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3177\/jnsv.30.475","article-title":"Intestinal absorption of thiamin in man compared with folate and pyridoxal and its subsequent urinary excretion","volume":"30","author":"Davis","year":"1984","journal-title":"J Nutr Sci Vitaminol (Tokyo)"},{"key":"10.1093\/ajcn\/75.4.616_bib148","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF00278489","article-title":"Plasma thiamine concentrations after intramuscular and oral multiple dosage regimens in healthy men","volume":"42","author":"Royer-Morrot","year":"1992","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1093\/ajcn\/75.4.616_bib149","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0196-0644(89)80215-X","article-title":"A toxicity study of parenteral thiamine hydrochloride","volume":"18","author":"Wrenn","year":"1989","journal-title":"Ann Emerg Med"},{"key":"10.1093\/ajcn\/75.4.616_bib150","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/prot.1093","article-title":"Adenine recognition: a motif present in ATP-, CoA-, NAD-, NADP-, and FAD-dependent proteins","volume":"44","author":"Denessiouk","year":"2001","journal-title":"Proteins"},{"key":"10.1093\/ajcn\/75.4.616_bib151","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1110\/ps.12801","article-title":"Sequence-structure analysis of FAD-containing proteins","volume":"10","author":"Dym","year":"2001","journal-title":"Protein Sci"},{"key":"10.1093\/ajcn\/75.4.616_bib152","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/ng0595-111","article-title":"A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase","volume":"10","author":"Frosst","year":"1995","journal-title":"Nat Genet"},{"key":"10.1093\/ajcn\/75.4.616_bib153","doi-asserted-by":"crossref","first-page":"12216","DOI":"10.1073\/pnas.96.22.12216","article-title":"Cancer prevention and diet: help from single nucleotide polymorphisms","volume":"96","author":"Ames","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1093\/ajcn\/75.4.616_bib154","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0015-0282(00)01697-6","article-title":"Low seminal plasma folate concentrations are associated with low sperm density and count in male smokers and nonsmokers","volume":"75","author":"Wallock","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1093\/ajcn\/75.4.616_bib155","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1161\/01.CIR.98.23.2520","article-title":"Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis","volume":"98","author":"Brattstreom","year":"1998","journal-title":"Circulation"},{"key":"10.1093\/ajcn\/75.4.616_bib156","first-page":"35","article-title":"Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease","volume":"58","author":"Kluijtmans","year":"1996","journal-title":"Am J Hum Genet"},{"key":"10.1093\/ajcn\/75.4.616_bib157","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1086\/302310","article-title":"The \u201cthermolabile\u201d variant of methylenetetrahydrofolate reductase and neural tube defects: an evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother","volume":"64","author":"Shields","year":"1999","journal-title":"Am J Hum Genet"},{"key":"10.1093\/ajcn\/75.4.616_bib158","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/ajcn\/70.4.495","article-title":"Abnormal folate metabolism and mutation in the methylenetetrahydrofolate reductase gene may be maternal risk factors for Down syndrome","volume":"70","author":"James","year":"1999","journal-title":"Am J Clin Nutr"},{"key":"10.1093\/ajcn\/75.4.616_bib159","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/1096-8628(20001204)96:6<762::AID-AJMG12>3.0.CO;2-X","article-title":"The homozygous C677T mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for migraine","volume":"96","author":"Kowa","year":"2000","journal-title":"Am J Med Genet"},{"key":"10.1093\/ajcn\/75.4.616_bib160","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/jn\/130.10.2493","article-title":"The association between two common mutations C677T and A1298C in human methylenetetrahydrofolate reductase gene and the risk for diabetic nephropathy in type II diabetic patients","volume":"130","author":"Shpichinetsky","year":"2000","journal-title":"J Nutr"},{"key":"10.1093\/ajcn\/75.4.616_bib161","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1067\/mob.2001.113845","article-title":"Association of the C677T methylenetetrahydrofolate reductase mutation and elevated homocysteine levels with congenital cardiac malformations","volume":"184","author":"Wenstrom","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1093\/ajcn\/75.4.616_bib162","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1161\/01.ATV.20.8.1921","article-title":"Pathogenicity of thermolabile methylenetetrahydrofolate reductase for vascular dementia","volume":"20","author":"Yoo","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1093\/ajcn\/75.4.616_bib163","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1056\/NEJM200104123441517","article-title":"Homozygous methylenetetrahydrofolate reductase C677T mutation and male infertility","volume":"344","author":"Bezold","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1093\/ajcn\/75.4.616_bib164","doi-asserted-by":"crossref","first-page":"14853","DOI":"10.1073\/pnas.261469998","article-title":"Effects of common polymorphisms on the properties of recombinant human methylenetetrahydrofolate reductase","volume":"98","author":"Yamada","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1093\/ajcn\/75.4.616_bib165","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/7594","article-title":"The structure and properties of methylenetetrahydrofolate reductase from Escherichia coli suggest how folate ameliorates human hyperhomocysteinemia","volume":"6","author":"Guenther","year":"1999","journal-title":"Nat Struct Biol"},{"key":"10.1093\/ajcn\/75.4.616_bib166","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1079\/BJN19860051","article-title":"The effect of riboflavin deficiency on methylenetetrahydrofolate reductase (NADPH) (EC 1.5.1.20) and folate metabolism in the rat","volume":"55","author":"Bates","year":"1986","journal-title":"Br J Nutr"},{"key":"10.1093\/ajcn\/75.4.616_bib167","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1093\/clinchem\/46.8.1065","article-title":"Riboflavin as a determinant of plasma total homocysteine: effect modification by the methylenetetrahydrofolate reductase C677T polymorphism","volume":"46","author":"Hustad","year":"2000","journal-title":"Clin Chem"},{"key":"10.1093\/ajcn\/75.4.616_bib168","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S1047-2797(97)00004-5","article-title":"Vitamin intake: a possible determinant of plasma homocyst(e)ine among middle-aged adults","volume":"7","author":"Shimakawa","year":"1997","journal-title":"Ann Epidemiol"},{"key":"10.1093\/ajcn\/75.4.616_bib169","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1212\/WNL.50.2.466","article-title":"Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial","volume":"50","author":"Schoenen","year":"1998","journal-title":"Neurology"},{"key":"10.1093\/ajcn\/75.4.616_bib170","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1046\/j.1526-4610.2000.00005.x","article-title":"Prophylactic treatment of migraine with beta-blockers and riboflavin: differential effects on the intensity dependence of auditory evoked cortical potentials","volume":"40","author":"Sandor","year":"2000","journal-title":"Headache"},{"key":"10.1093\/ajcn\/75.4.616_bib171","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s004310050860","article-title":"Evaluation of the MTHFR C677T allele and the MTHFR gene locus in a German spina bifida population","volume":"157","author":"Koch","year":"1998","journal-title":"Eur J Pediatr"},{"key":"10.1093\/ajcn\/75.4.616_bib172","first-page":"703","article-title":"Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects","volume":"86","author":"Kirke","year":"1993","journal-title":"Q J Med"},{"key":"10.1093\/ajcn\/75.4.616_bib173","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2165\/00128072-200002060-00003","article-title":"Primary prevention of neural-tube defects and some other major congenital abnormalities: recommendations for the appropriate use of folic acid during pregnancy","volume":"2","author":"Czeizel","year":"2000","journal-title":"Paediatr Drugs"},{"key":"10.1093\/ajcn\/75.4.616_bib174","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0165-6147(00)01675-8","article-title":"Biological and clinical implications of the MTHFR C677T polymorphism","volume":"22","author":"Ueland","year":"2001","journal-title":"Trends Pharmacol Sci"},{"key":"10.1093\/ajcn\/75.4.616_bib175","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1046\/j.1523-1755.2001.0600031106.x","article-title":"An MTHFR variant, homocysteine, and cardiovascular comorbidity in renal disease","volume":"60","author":"Wrone","year":"2001","journal-title":"Kidney Int"},{"key":"10.1093\/ajcn\/75.4.616_bib176","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S0002-9149(00)01103-6","article-title":"Effect of common methylenetetrahydrofolate reductase gene mutation on coronary artery disease in familial hypercholesterolemia","volume":"86","author":"Kawashiri","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1093\/ajcn\/75.4.616_bib177","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1161\/01.CIR.95.8.2032","article-title":"Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease","volume":"95","author":"Morita","year":"1997","journal-title":"Circulation"},{"key":"10.1093\/ajcn\/75.4.616_bib178","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1161\/01.CIR.94.9.2154","article-title":"Homocysteine and risk of premature coronary heart disease. Evidence for a common gene mutation","volume":"94","author":"Gallagher","year":"1996","journal-title":"Circulation"},{"key":"10.1093\/ajcn\/75.4.616_bib179","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1086\/303055","article-title":"Polymorphisms in genes involved in folate metabolism as maternal risk factors for Down syndrome","volume":"67","author":"Hobbs","year":"2000","journal-title":"Am J Hum Genet"},{"key":"10.1093\/ajcn\/75.4.616_bib180","first-page":"849","article-title":"Genomic DNA hypomethylation, a characteristic of most cancers, is present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphism in the methylenetetrahydrofolate reductase gene","volume":"9","author":"Stern","year":"2000","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1093\/ajcn\/75.4.616_bib181","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0008-6363(01)00286-3","article-title":"Infant methylenetetrahydrofolate reductase 677TT genotype is a risk factor for congenital heart disease","volume":"51","author":"Junker","year":"2001","journal-title":"Cardiovasc Res"},{"key":"10.1093\/ajcn\/75.4.616_bib182","first-page":"1052","article-title":"Seven novel mutations in the methylenetetrahydrofolate reductase gene and genotype\/ phenotype correlations in severe methylenetetrahydrofolate reductase deficiency","volume":"56","author":"Goyette","year":"1995","journal-title":"Am J Hum Genet"},{"key":"10.1093\/ajcn\/75.4.616_bib183","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1203\/00006450-197711000-00005","article-title":"Methylenetetrahydrofolate reductase in cultured human cells. II. Genetic and biochemical studies of methylenetetrahydrofolate reductase deficiency","volume":"11","author":"Rosenblatt","year":"1977","journal-title":"Pediatr Res"},{"key":"10.1093\/ajcn\/75.4.616_bib184","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1161\/01.CIR.93.1.7","article-title":"Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations","volume":"93","author":"Jacques","year":"1996","journal-title":"Circulation"},{"key":"10.1093\/ajcn\/75.4.616_bib185","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1161\/01.CIR.94.10.2410","article-title":"Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians","volume":"94","author":"Ma","year":"1996","journal-title":"Circulation"},{"key":"10.1093\/ajcn\/75.4.616_bib186","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0009-2797(00)00199-X","article-title":"NAD(P)H:quinone oxidoreductase 1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphisms","volume":"129","author":"Ross","year":"2000","journal-title":"Chem Biol Interact"},{"key":"10.1093\/ajcn\/75.4.616_bib187","first-page":"3045","article-title":"Association of the NAD(P)H:quinone oxidoreductase 609C\u2192T polymorphism with a decreased lung cancer risk","volume":"59","author":"Chen","year":"1999","journal-title":"Cancer Res"},{"key":"10.1093\/ajcn\/75.4.616_bib188","first-page":"87","article-title":"Lung cancer in Mexican-Americans and African-Americans is associated with the wild-type genotype of the NAD(P)H:quinone oxidoreductase polymorphism","volume":"6","author":"Wiencke","year":"1997","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1093\/ajcn\/75.4.616_bib189","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/00008571-199508000-00003","article-title":"Identification of an NAD(P)H:quinone oxidoreductase polymorphism and its association with lung cancer and smoking","volume":"5","author":"Rosvold","year":"1995","journal-title":"Pharmacogenetics"},{"key":"10.1093\/ajcn\/75.4.616_bib190","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0169-5002(01)00243-4","article-title":"Polymorphisms in the NAD(P)H:quinone oxidoreductase gene and small cell lung cancer risk in a UK population","volume":"34","author":"Lewis","year":"2001","journal-title":"Lung Cancer"},{"key":"10.1093\/ajcn\/75.4.616_bib191","first-page":"303","article-title":"The NAD(P)H:quinone oxidoreductase 1 gene polymorphism and lung cancer: differential susceptibility based on smoking behavior","volume":"10","author":"Xu","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1093\/ajcn\/75.4.616_bib192","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1124\/mol.56.2.272","article-title":"Molecular characterization of binding of substrates and inhibitors to DT-diaphorase: combined approach involving site-directed mutagenesis, inhibitor-binding analysis, and computer modeling","volume":"56","author":"Chen","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1093\/ajcn\/75.4.616_bib193","series-title":"Pathophysiology of lipid peroxides and related free radicals.","first-page":"135","article-title":"Catalytic properties of a natural occurring mutant of human NAD(P)H:quinone acceptor oxidoreductase (DT-diaphorase), Pro 187 to Ser","author":"Wu","year":"1998"},{"key":"10.1093\/ajcn\/75.4.616_bib194","first-page":"67","article-title":"Characteristics of human protoporphyrinogen oxidase in controls and variegate porphyrias","volume":"43","author":"Dailey","year":"1997","journal-title":"Cell Mol Biol"},{"key":"10.1093\/ajcn\/75.4.616_bib195","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/(SICI)1096-8628(19980827)79:1<22::AID-AJMG6>3.0.CO;2-K","article-title":"Recurrent missense mutation in the protoporphyrinogen oxidase gene underlies variegate porphyria","volume":"79","author":"Frank","year":"1998","journal-title":"Am J Med Genet"},{"key":"10.1093\/ajcn\/75.4.616_bib196","series-title":"The metabolic and molecular bases of inherited disease.","first-page":"1611","article-title":"Chapter 47. Nuclear-encoded defects of the mitochondrial respiratory chain, including glutaric acidemia type II","author":"Frerman","year":"1995"},{"key":"10.1093\/ajcn\/75.4.616_bib197","doi-asserted-by":"crossref","first-page":"26425","DOI":"10.1074\/jbc.272.42.26425","article-title":"Expression and characterization of two pathogenic mutations in human electron transfer flavoprotein","volume":"272","author":"Salazar","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1093\/ajcn\/75.4.616_bib198","doi-asserted-by":"crossref","first-page":"14355","DOI":"10.1073\/pnas.93.25.14355","article-title":"Three-dimensional structure of human electron transfer flavoprotein to 2.1-\u00c5 resolution","volume":"93","author":"Roberts","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1093\/ajcn\/75.4.616_bib199","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/jnnp.55.3.209","article-title":"Neuropsychiatric manifestations of defect in mitochondrial beta oxidation response to riboflavin","volume":"55","author":"Triggs","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1093\/ajcn\/75.4.616_bib200","first-page":"271A","article-title":"Mutations in electron transfer flavoprotein:ubiquinone oxidoreductase (ETF:QO) in glutaric acidemia type II (GA2)","volume":"41","author":"Beard","year":"1993","journal-title":"Clin Res"},{"key":"10.1093\/ajcn\/75.4.616_bib201","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1172\/JCI112553","article-title":"The multiple acyl-coenzyme A dehydrogenation disorders, glutaric aciduria type II and ethylmalonic-adipic aciduria. Mitochondrial fatty acid oxidation, acyl-coenzyme A dehydrogenase, and electron transfer flavoprotein activities in fibroblasts","volume":"78","author":"Amendt","year":"1986","journal-title":"J Clin Invest"},{"key":"10.1093\/ajcn\/75.4.616_bib202","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0887-8994(95)00187-5","article-title":"Riboflavin-responsive glutaric aciduria type II presenting as a leukodystrophy","volume":"13","author":"Uziel","year":"1995","journal-title":"Pediatr Neurol"},{"key":"10.1093\/ajcn\/75.4.616_bib203","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF01801667","article-title":"Riboflavin-responsive ethylmalonic-adipic aciduria","volume":"8","author":"Green","year":"1985","journal-title":"J Inherit Metab Dis"},{"key":"10.1093\/ajcn\/75.4.616_bib204","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0168-8278(97)80063-3","article-title":"Ethylmalonic adipic aciduria\u2014a treatable hepatomuscular disorder in two adult brothers","volume":"26","author":"Elias","year":"1997","journal-title":"J Hepatol"},{"key":"10.1093\/ajcn\/75.4.616_bib205","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/sj.jp.7200325","article-title":"Glutaric aciduria type II: observations in seven patients with neonatal- and late-onset disease","volume":"20","author":"al-Essa","year":"2000","journal-title":"J Perinatol"},{"key":"10.1093\/ajcn\/75.4.616_bib206","first-page":"575","volume":"49","author":"Indo","year":"1991","journal-title":"Am J Hum Genet"},{"key":"10.1093\/ajcn\/75.4.616_bib207","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/BF01799588","article-title":"A new variant of glutaric aciduria type II: deficiency of beta-subunit of electron transfer flavoprotein","volume":"13","author":"Yamaguchi","year":"1990","journal-title":"J Inherit Metab Dis"},{"key":"10.1093\/ajcn\/75.4.616_bib208","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF01800589","article-title":"Atypical riboflavin-responsive glutaric aciduria, and deficient peroxisomal glutaryl-CoA oxidase activity: a new peroxisomal disorder","volume":"14","author":"Bennett","year":"1991","journal-title":"J Inherit Metab Dis"},{"key":"10.1093\/ajcn\/75.4.616_bib209","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF00711774","article-title":"Riboflavin-responsive epilepsy in a patient with SER209 variant form of short-chain acyl-CoA dehydrogenase","volume":"18","author":"Kmoch","year":"1995","journal-title":"J Inherit Metab Dis"},{"key":"10.1093\/ajcn\/75.4.616_bib210","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/ana.410250510","article-title":"Normalization of short-chain acylcoenzyme A dehydrogenase after riboflavin treatment in a girl with multiple acylcoenzyme A dehydrogenase-deficient myopathy","volume":"25","author":"DiDonato","year":"1989","journal-title":"Ann Neurol"},{"key":"10.1093\/ajcn\/75.4.616_bib211","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1203\/00006450-198210000-00012","article-title":"C6-C10-dicarboxylic aciduria: investigations of a patient with riboflavin responsive multiple acyl-CoA dehydrogenation defects","volume":"16","author":"Gregersen","year":"1982","journal-title":"Pediatr Res"},{"key":"10.1093\/ajcn\/75.4.616_bib212","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1007\/s004310050717","article-title":"Stridor as the major presenting symptom in riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency","volume":"156","author":"Sperl","year":"1997","journal-title":"Eur J Pediatr"},{"key":"10.1093\/ajcn\/75.4.616_bib213","first-page":"163","article-title":"A case of riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency (glutaric aciduria type II)","volume":"32","author":"Tojo","year":"2000","journal-title":"No To Hattatsu"},{"key":"10.1093\/ajcn\/75.4.616_bib214","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0022-510X(93)90108-B","article-title":"Treatment of complex I deficiency with riboflavin","volume":"118","author":"Bernsen","year":"1993","journal-title":"J Neurol Sci"},{"key":"10.1093\/ajcn\/75.4.616_bib215","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1067\/mpd.2001.118885","article-title":"Effect of various agents on adenosine triphosphate synthesis in mitochondrial complex I deficiency","volume":"139","author":"Bar-Meir","year":"2001","journal-title":"J Pediatr"},{"key":"10.1093\/ajcn\/75.4.616_bib216","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1001\/archneur.1991.00530150106028","article-title":"Successful treatment of pure myopathy, associated with complex I deficiency, with riboflavin and carnitine","volume":"48","author":"Bernsen","year":"1991","journal-title":"Arch Neurol"},{"key":"10.1093\/ajcn\/75.4.616_bib217","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1469-8749.1990.tb16979.x","article-title":"A mitochondrial myopathy in an infant with lactic acidosis","volume":"32","author":"Griebel","year":"1990","journal-title":"Dev Med Child Neurol"},{"key":"10.1093\/ajcn\/75.4.616_bib218","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0925-4439(95)00013-T","article-title":"Riboflavin-responsive complex I deficiency","volume":"1271","author":"Scholte","year":"1995","journal-title":"Biochim Biophys Acta"},{"key":"10.1093\/ajcn\/75.4.616_bib219","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0022-3476(97)70323-8","article-title":"Mitochondrial myopathy with tRNA(Leu(UUR)) mutation and complex I deficiency responsive to riboflavin","volume":"130","author":"Ogle","year":"1997","journal-title":"J Pediatr"},{"key":"10.1093\/ajcn\/75.4.616_bib220","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1212\/WNL.42.11.2147","article-title":"MELAS syndrome with mitochondrial tRNA(Leu)(UUR) mutation: correlation of clinical state, nerve conduction, and muscle 31P magnetic resonance spectroscopy during treatment with nicotinamide and riboflavin","volume":"42","author":"Penn","year":"1992","journal-title":"Neurology"},{"key":"10.1093\/ajcn\/75.4.616_bib221","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/348651a0","article-title":"A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies","volume":"348","author":"Goto","year":"1990","journal-title":"Nature"},{"key":"10.1093\/ajcn\/75.4.616_bib222","first-page":"237","article-title":"The metabolism of riboflavin in female patients with liver cirrhosis","volume":"66","author":"Zempleni","year":"1996","journal-title":"Int J Vitam Nutr Res"},{"key":"10.1093\/ajcn\/75.4.616_bib223","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1093\/ajcn\/63.1.54","article-title":"Pharmacokinetics of orally and intravenously administered riboflavin in healthy humans","volume":"63","author":"Zempleni","year":"1996","journal-title":"Am J Clin Nutr"},{"key":"10.1093\/ajcn\/75.4.616_bib224","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0969-2126(97)00224-4","article-title":"Structure of mitochondrial aldehyde dehydrogenase: the genetic component of ethanol aversion","volume":"5","author":"Steinmetz","year":"1997","journal-title":"Structure"},{"key":"10.1093\/ajcn\/75.4.616_bib225","doi-asserted-by":"crossref","first-page":"13854","DOI":"10.1016\/S0021-9258(17)36725-X","article-title":"Effects of changing glutamate 487 to lysine in rat and human liver mitochondrial aldehyde dehydrogenase. A model to study human (Oriental type) class 2 aldehyde dehydrogenase","volume":"269","author":"Farres","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1093\/ajcn\/75.4.616_bib226","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S1368-8375(99)00048-2","article-title":"Aldehyde dehydrogenase 2 and glutathione S-transferase M 1 polymorphisms in relation to the risk for oral cancer in Japanese drinkers","volume":"36","author":"Nomura","year":"2000","journal-title":"Oral Oncol"},{"key":"10.1093\/ajcn\/75.4.616_bib227","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/carcin\/22.3.433","article-title":"Alcohol and aldehyde dehydrogenase gene polymorphisms and oropharyngolaryngeal, esophageal and stomach cancers in Japanese alcoholics","volume":"22","author":"Yokoyama","year":"2001","journal-title":"Carcinogenesis"},{"key":"10.1093\/ajcn\/75.4.616_bib228","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1006\/bbrc.2000.2923","article-title":"Deficiency in mitochondrial aldehyde dehydrogenase increases the risk for late-onset Alzheimer\u2019s disease in the Japanese population","volume":"273","author":"Kamino","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1093\/ajcn\/75.4.616_bib229","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1620\/tjem.187.311","article-title":"The role of alcohol dehydrogenase 2 and aldehyde dehydrogenase 2 genotypes in alcohol-induced vasospastic angina","volume":"187","author":"Seki","year":"1999","journal-title":"Tohoku J Exp Med"},{"issue":"suppl","key":"10.1093\/ajcn\/75.4.616_bib230","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/S0168-8227(00)00174-1","article-title":"Genetic and environmental interaction in Japanese type 2 diabetics","volume":"50","author":"Matsuoka","year":"2000","journal-title":"Diabetes Res Clin Pract"},{"issue":"suppl","key":"10.1093\/ajcn\/75.4.616_bib231","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1111\/j.1530-0277.2000.tb00003.x","article-title":"Inactive aldehyde dehydrogenase 2 worsens glycemic control in patients with type 2 diabetes mellitus who drink low to moderate amounts of alcohol","volume":"24","author":"Murata","year":"2000","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1093\/ajcn\/75.4.616_bib232","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1172\/JCI110043","article-title":"Acetaldehyde adducts with hemoglobin","volume":"67","author":"Stevens","year":"1981","journal-title":"J Clin Invest"},{"key":"10.1093\/ajcn\/75.4.616_bib233","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1023\/A:1005650902961","article-title":"Alcohol and aldehyde dehydrogenase polymorphisms in Japanese patients with alcohol-induced chronic pancreatitis","volume":"45","author":"Kimura","year":"2000","journal-title":"Dig Dis Sci"},{"key":"10.1093\/ajcn\/75.4.616_bib234","doi-asserted-by":"crossref","first-page":"31172","DOI":"10.1074\/jbc.271.49.31172","article-title":"Heterotetramers of human liver mitochondrial (class 2) aldehyde dehydrogenase expressed in Escherichia coli. A model to study the heterotetramers expected to be found in Oriental people","volume":"271","author":"Wang","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1093\/ajcn\/75.4.616_bib235","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0165-1161(89)90005-8","article-title":"Effect of nicotinic acid supplementation in vivo on oxygen radical-induced genetic damage in human lymphocytes","volume":"216","author":"Weitberg","year":"1989","journal-title":"Mutat Res"},{"key":"10.1093\/ajcn\/75.4.616_bib236","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0024-3205(96)80008-7","article-title":"Increase of blood NAD+ and attenuation of lactacidemia during nicotinamide treatment of a patient with the MELAS syndrome","volume":"58","author":"Majamaa","year":"1996","journal-title":"Life Sci"},{"key":"10.1093\/ajcn\/75.4.616_bib237","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/(SICI)1097-0215(20000601)86:5<626::AID-IJC4>3.0.CO;2-Y","article-title":"Role of macronutrients, vitamins and minerals in the aetiology of squamous-cell carcinoma of the oesophagus","volume":"86","author":"Franceschi","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1093\/ajcn\/75.4.616_bib238","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1074\/jbc.274.5.2750","article-title":"Enhanced glutathione levels and oxidoresistance mediated by increased glucose-6-phosphate dehydrogenase expression","volume":"274","author":"Salvemini","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1093\/ajcn\/75.4.616_bib239","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/(SICI)1096-8652(199602)51:2<122::AID-AJH5>3.0.CO;2-#","article-title":"Molecular basis of erythroenzymopathies associated with hereditary hemolytic anemia: tabulation of mutant enzymes","volume":"51","author":"Miwa","year":"1996","journal-title":"Am J Hematol"},{"key":"10.1093\/ajcn\/75.4.616_bib240","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1096\/fasebj.14.3.485","article-title":"Human mutations in glucose 6-phosphate dehydrogenase reflect evolutionary history","volume":"14","author":"Notaro","year":"2000","journal-title":"FASEB J"},{"key":"10.1093\/ajcn\/75.4.616_bib241","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0168-9525(92)90080-N","article-title":"The molecular basis of glucose-6-phosphate dehydrogenase deficiency","volume":"8","author":"Vulliamy","year":"1992","journal-title":"Trends Genet"},{"key":"10.1093\/ajcn\/75.4.616_bib242","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/ajcn\/71.2.530","article-title":"Ascorbate is depleted by smoking and repleted by moderate supplementation: a study in male smokers and nonsmokers with matched dietary antioxidant intakes","volume":"71","author":"Lykkesfeldt","year":"2000","journal-title":"Am J Clin Nutr"},{"key":"10.1093\/ajcn\/75.4.616_bib243","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.1073\/pnas.85.14.5171","article-title":"Diverse point mutations in the human glucose-6-phosphate dehydrogenase gene cause enzyme deficiency and mild or severe hemolytic anemia","volume":"85","author":"Vulliamy","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1093\/ajcn\/75.4.616_bib244","first-page":"1335","article-title":"A new glucose-6-phosphate dehydrogenase variant, G6PD Orissa (44 Ala\u2192Gly), is the major polymorphic variant in tribal populations in India","volume":"57","author":"Kaeda","year":"1995","journal-title":"Am J Hum Genet"},{"key":"10.1093\/ajcn\/75.4.616_bib245","first-page":"2955","article-title":"Molecular basis and enzymatic properties of glucose 6-phosphate dehydrogenase volendam, leading to chronic nonspherocytic anemia, granulocyte dysfunction, and increased susceptibility to infections","volume":"94","author":"Roos","year":"1999","journal-title":"Blood"},{"key":"10.1093\/ajcn\/75.4.616_bib246","doi-asserted-by":"crossref","first-page":"10015","DOI":"10.1073\/pnas.86.24.10015","article-title":"Identification of the binding domain for NADP+ of human glucose-6-phosphate dehydrogenase by sequence analysis of mutants","volume":"86","author":"Hirono","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1093\/ajcn\/75.4.616_bib247","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.1016\/S0021-9258(20)64298-3","article-title":"DNA sequence abnormalities of human glucose-6-phosphate dehydrogenase variants","volume":"266","author":"Beutler","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1093\/ajcn\/75.4.616_bib248","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0969-2126(00)00104-0","article-title":"Human glucose-6-phosphate dehydrogenase: the crystal structure reveals a structural NADP(+) molecule and provides insights into enzyme deficiency","volume":"8","author":"Au","year":"2000","journal-title":"Structure Fold Des"},{"key":"10.1093\/ajcn\/75.4.616_bib249","unstructured":"National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health. NCBI BLAST home page. Version current 29 January 2001. Internet: http:\/\/www.ncbi.nlm.nih.gov\/BLAST\/ (accessed 2 February 2002)."},{"key":"10.1093\/ajcn\/75.4.616_bib250","unstructured":"Blau N. Tetrahydrobiopterin home page. Version current 14 January 2002. Internet: http:\/\/www.bh4.org (accessed 2 February 2002)."},{"key":"10.1093\/ajcn\/75.4.616_bib251","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/(SICI)1098-1004(1999)13:6<503::AID-HUMU13>3.0.CO;2-F","article-title":"A series of mutations in the dihydropteridine reductase gene resulting in either abnormal RNA splicing or DHPR protein defects. Mutations in brief no. 244. Online","volume":"13","author":"Smooker","year":"1999","journal-title":"Hum Mutat"},{"key":"10.1093\/ajcn\/75.4.616_bib252","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0925-4439(97)00016-1","article-title":"NADH stimulates endogenous dopamine biosynthesis by enhancing the recycling of tetrahydrobiopterin in rat phaeochromocytoma cells","volume":"1361","author":"Vrecko","year":"1997","journal-title":"Biochim Biophys Acta"},{"key":"10.1093\/ajcn\/75.4.616_bib253","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0022-3476(99)70138-1","article-title":"Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency","volume":"135","author":"Kure","year":"1999","journal-title":"J Pediatr"},{"key":"10.1093\/ajcn\/75.4.616_bib254","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/ajcn\/30.2.198","article-title":"Nutrient intake of treated infants with phenylketonuria","volume":"30","author":"Acosta","year":"1977","journal-title":"Am J Clin Nutr"},{"key":"10.1093\/ajcn\/75.4.616_bib255","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1073\/pnas.92.3.841","article-title":"The molecular basis of pediatric long chain 3-hydroxyacyl-CoA dehydrogenase deficiency associated with maternal acute fatty liver of pregnancy","volume":"92","author":"Sims","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1093\/ajcn\/75.4.616_bib256","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1172\/JCI118863","volume":"98","author":"Ijlst","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1093\/ajcn\/75.4.616_bib257","unstructured":"National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health. Conserved domain database. NCBI CD-search. Internet: http:\/\/www.ncbi.nlm.nih.gov\/Structure\/cdd\/wrpsb.cgi (accessed 2 February 2002)."},{"key":"10.1093\/ajcn\/75.4.616_bib258","doi-asserted-by":"crossref","first-page":"8262","DOI":"10.1073\/pnas.84.23.8262","article-title":"Structure of l-3-hydroxyacyl-coenzyme A dehydrogenase: preliminary chain tracing at 2.8-\u00c5 resolution","volume":"84","author":"Birktoft","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1093\/ajcn\/75.4.616_bib259","doi-asserted-by":"crossref","first-page":"52B","DOI":"10.1016\/S0002-9149(98)00039-3","article-title":"Use of niacin, statins, and resins in patients with combined hyperlipidemia","volume":"81","author":"Brown","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1093\/ajcn\/75.4.616_bib260","doi-asserted-by":"crossref","first-page":"82U","DOI":"10.1016\/S0002-9149(98)00955-2","article-title":"Treatment of hyperlipidemia with combined niacin-statin regimens","volume":"82","author":"Guyton","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1093\/ajcn\/75.4.616_bib261","doi-asserted-by":"crossref","first-page":"18U","DOI":"10.1016\/S0002-9149(98)00767-X","article-title":"Effect of niacin on atherosclerotic cardiovascular disease","volume":"82","author":"Guyton","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1093\/ajcn\/75.4.616_bib262","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1001\/archinte.1991.00400070172024","article-title":"Niacin revisited. A randomized, controlled trial of wax-matrix sustained-release niacin in hypercholesterolemia","volume":"151","author":"Keenan","year":"1991","journal-title":"Arch Intern Med"},{"key":"10.1093\/ajcn\/75.4.616_bib263","first-page":"3","article-title":"Role of nicotinic acid and its derivatives in disorders of nervous system function","volume":"67","author":"Parkhomets","year":"1995","journal-title":"Ukr Biokhim Zh"},{"key":"10.1093\/ajcn\/75.4.616_bib264","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1177\/070674377101600605","article-title":"Megavitamin B-3 therapy for schizophrenia","volume":"16","author":"Hoffer","year":"1971","journal-title":"Can Psychiatr Assoc J"},{"key":"10.1093\/ajcn\/75.4.616_bib265","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1176\/ajp.131.11.1251","article-title":"On the orthomolecular environment of the mind: orthomolecular theory","volume":"131","author":"Pauling","year":"1974","journal-title":"Am J Psychiatry"},{"key":"10.1093\/ajcn\/75.4.616_bib266","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1176\/ajp.131.11.1258","article-title":"Comment","volume":"131","author":"Wyatt","year":"1974","journal-title":"Am J Psychiatry"},{"key":"10.1093\/ajcn\/75.4.616_bib267","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1081-1206(10)62595-1","article-title":"Therapeutic effects of oral NADH on the symptoms of patients with chronic fatigue syndrome","volume":"82","author":"Forsyth","year":"1999","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1093\/ajcn\/75.4.616_bib268","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1365-2133.1988.tb02572.x","article-title":"High dose nicotinamide in the treatment of necrobiosis lipoidica","volume":"118","author":"Handfield-Jones","year":"1988","journal-title":"Br J Dermatol"},{"key":"10.1093\/ajcn\/75.4.616_bib269","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1207\/S15327914NC340105","article-title":"Oral niacin prevents photocarcinogenesis and photoimmunosuppression in mice","volume":"34","author":"Gensler","year":"1999","journal-title":"Nutr Cancer"},{"key":"10.1093\/ajcn\/75.4.616_bib270","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1093\/jn\/125.6.1455","article-title":"Large supplements of nicotinic acid and nicotinamide increase tissue NAD+ and poly(ADP-ribose) levels but do not affect diethylnitrosamine-induced altered hepatic foci in Fischer-344 rats","volume":"125","author":"Jackson","year":"1995","journal-title":"J Nutr"},{"key":"10.1093\/ajcn\/75.4.616_bib271","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/jps.2600660635","article-title":"GI absorption of niacin in humans","volume":"66","author":"Bechgaard","year":"1977","journal-title":"J Pharm Sci"},{"key":"10.1093\/ajcn\/75.4.616_bib272","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1006\/mgme.1998.2700","article-title":"Deficiency of biotinyl-AMP synthetase activity in fibroblasts of patients with holocarboxylase synthetase deficiency","volume":"64","author":"Morita","year":"1998","journal-title":"Mol Genet Metab"},{"key":"10.1093\/ajcn\/75.4.616_bib273","series-title":"The metabolic and molecular bases of inherited disease.","first-page":"3151","article-title":"Chapter 103. Disorders of biotin metabolism","author":"Wolf","year":"1995"},{"key":"10.1093\/ajcn\/75.4.616_bib274","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0140-6736(79)90002-3","article-title":"Multiple biotin-dependent carboxylase deficiencies associated with defects in T-cell and B-cell immunity","volume":"2","author":"Cowan","year":"1979","journal-title":"Lancet"},{"key":"10.1093\/ajcn\/75.4.616_bib275","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/S0140-6736(82)92452-7","article-title":"Prenatal treatment of biotin responsive multiple carboxylase deficiency","volume":"1","author":"Packman","year":"1982","journal-title":"Lancet"},{"key":"10.1093\/ajcn\/75.4.616_bib276","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0009-8981(96)06291-2","article-title":"Enzymatic diagnosis of holocarboxylase synthetase deficiency using apo-carboxyl carrier protein as a substrate","volume":"251","author":"Suzuki","year":"1996","journal-title":"Clin Chim Acta"},{"key":"10.1093\/ajcn\/75.4.616_bib277","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1203\/00006450-199712000-00021","article-title":"Characterization of mutant holocarboxylase synthetase (HCS): a Km for biotin was not elevated in a patient with HCS deficiency","volume":"42","author":"Aoki","year":"1997","journal-title":"Pediatr Res"},{"key":"10.1093\/ajcn\/75.4.616_bib278","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1093\/hmg\/5.7.1011","article-title":"Clustering of mutations in the biotin-binding region of holocarboxylase synthetase in biotin-responsive multiple carboxylase deficiency","volume":"5","author":"Dupuis","year":"1996","journal-title":"Hum Mol Genet"},{"key":"10.1093\/ajcn\/75.4.616_bib279","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1203\/00006450-199912000-00004","article-title":"Relationship between kinetic properties of mutant enzyme and biochemical and clinical responsiveness to biotin in holocarboxylase synthetase deficiency","volume":"46","author":"Sakamoto","year":"1999","journal-title":"Pediatr Res"},{"key":"10.1093\/ajcn\/75.4.616_bib280","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0009-8981(99)00053-4","article-title":"Prenatal diagnosis of holocarboxylase synthetase deficiency by assay of the enzyme in chorionic villus material followed by prenatal treatment","volume":"284","author":"Thuy","year":"1999","journal-title":"Clin Chim Acta"},{"key":"10.1093\/ajcn\/75.4.616_bib281","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/(SICI)1097-0223(199902)19:2<108::AID-PD476>3.0.CO;2-E","article-title":"Prenatal diagnosis and treatment of holocarboxylase synthetase deficiency","volume":"19","author":"Thuy","year":"1999","journal-title":"Prenat Diagn"},{"key":"10.1093\/ajcn\/75.4.616_bib282","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1203\/00006450-199705000-00011","article-title":"Five patients with a biotin-responsive defect in holocarboxylase formation: evaluation of responsiveness to biotin therapy in vivo and comparative biochemical studies in vitro","volume":"41","author":"Suormala","year":"1997","journal-title":"Pediatr Res"},{"key":"10.1093\/ajcn\/75.4.616_bib283","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s004390050927","article-title":"Identification and characterization of mutations in patients with holocarboxylase synthetase deficiency","volume":"104","author":"Aoki","year":"1999","journal-title":"Hum Genet"},{"key":"10.1093\/ajcn\/75.4.616_bib284","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/ajcn\/69.3.504","article-title":"Bioavailability of biotin given orally to humans in pharmacologic doses","volume":"69","author":"Zempleni","year":"1999","journal-title":"Am J Clin Nutr"},{"key":"10.1093\/ajcn\/75.4.616_bib285","first-page":"326","article-title":"Heterogeneity of holocarboxylase synthetase in patients with biotin-responsive multiple carboxylase deficiency","volume":"37","author":"Burri","year":"1985","journal-title":"Am J Hum Genet"},{"key":"10.1093\/ajcn\/75.4.616_bib286","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1093\/jn\/131.5.1479","article-title":"In vivo biotin supplementation at a pharmacologic dose decreases proliferation rates of human peripheral blood mononuclear cells and cytokine release","volume":"131","author":"Zempleni","year":"2001","journal-title":"J Nutr"},{"key":"10.1093\/ajcn\/75.4.616_bib287","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1056\/NEJM198410183111604","article-title":"Benign methylmalonic aciduria","volume":"311","author":"Ledley","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1093\/ajcn\/75.4.616_bib288","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/0006-291X(77)90511-3","article-title":"Inherited deficiencies of human methylmalonyl CoA mutase activity: reduced affinity of mutant apoenzyme for adenosylcobalamin","volume":"78","author":"Willard","year":"1977","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1093\/ajcn\/75.4.616_bib289","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1172\/JCI109715","article-title":"Inherited methylmalonyl CoA mutase apoenzyme deficiency in human fibroblasts: evidence for allelic heterogeneity, genetic compounds, and codominant expression","volume":"65","author":"Willard","year":"1980","journal-title":"J Clin Invest"},{"key":"10.1093\/ajcn\/75.4.616_bib290","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0009-8981(78)90102-X","article-title":"A new variant of methylmalonic acidemia-defective coenzyme-apoenzyme binding in cultured fibroblasts","volume":"85","author":"Morrow","year":"1978","journal-title":"Clin Chim Acta"},{"key":"10.1093\/ajcn\/75.4.616_bib291","doi-asserted-by":"crossref","first-page":"5550","DOI":"10.1073\/pnas.93.11.5550","article-title":"Molecular basis for dysfunction of some mutant forms of methylmalonyl-CoA mutase: deductions from the structure of methionine synthase","volume":"93","author":"Drennan","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1093\/ajcn\/75.4.616_bib292","first-page":"42","article-title":"Clustering of mutations in methylmalonyl CoA mutase associated with mut-methylmalonic acidemia","volume":"55","author":"Crane","year":"1994","journal-title":"Am J Hum Genet"},{"key":"10.1093\/ajcn\/75.4.616_bib293","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1172\/JCI115597","article-title":"Cloning and expression of a mutant methylmalonyl coenzyme A mutase with altered cobalamin affinity that causes mut-methylmalonic aciduria","volume":"89","author":"Crane","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1093\/ajcn\/75.4.616_bib294","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1093\/hmg\/8.11.2009","article-title":"Molecular basis for methionine synthase reductase deficiency in patients belonging to the cblE complementation group of disorders in folate\/cobalamin metabolism","volume":"8","author":"Wilson","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1093\/ajcn\/75.4.616_bib295","series-title":"The metabolic and molecular bases of inherited disease.","first-page":"3129","article-title":"Chapter 102. Inherited disorders of cobalamin transport and metabolism","author":"Fenton","year":"1995"},{"key":"10.1093\/ajcn\/75.4.616_bib296","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S0140-6736(85)92433-X","article-title":"Prenatal vitamin B12 therapy of a fetus with methylcobalamin deficiency (cobalamin E disease)","volume":"1","author":"Rosenblatt","year":"1985","journal-title":"Lancet"},{"key":"10.1093\/ajcn\/75.4.616_bib297","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1093\/hmg\/5.12.1859","article-title":"Defects in human methionine synthase in cblG patients","volume":"5","author":"Gulati","year":"1996","journal-title":"Hum Mol Genet"},{"key":"10.1093\/ajcn\/75.4.616_bib298","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1093\/hmg\/5.12.1867","article-title":"Human methionine synthase: cDNA cloning and identification of mutations in patients of the cblG complementation group of folate\/cobalamin disorders","volume":"5","author":"Leclerc","year":"1996","journal-title":"Hum Mol Genet"},{"key":"10.1093\/ajcn\/75.4.616_bib299","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0021-9150(00)00469-X","article-title":"Influence of a methionine synthase (D919G) polymorphism on plasma homocysteine and folate levels and relation to risk of myocardial infarction","volume":"154","author":"Chen","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1093\/ajcn\/75.4.616_bib300","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/(SICI)1098-2272(199911)17:4<298::AID-GEPI5>3.0.CO;2-V","article-title":"Methionine synthase D919G polymorphism is a significant but modest determinant of circulating homocysteine concentrations","volume":"17","author":"Harmon","year":"1999","journal-title":"Genet Epidemiol"},{"key":"10.1093\/ajcn\/75.4.616_bib301","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/(SICI)1096-8628(19970905)71:4<384::AID-AJMG3>3.0.CO;2-U","article-title":"Functional methionine synthase deficiency due to cblG disorder: a report of two patients and a review","volume":"71","author":"Harding","year":"1997","journal-title":"Am J Med Genet"},{"key":"10.1093\/ajcn\/75.4.616_bib302","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/0885-4505(92)90032-T","article-title":"Heterogeneity in cblG: differential retention of cobalamin on methionine synthase","volume":"47","author":"Sillaots","year":"1992","journal-title":"Biochem Med Metab Biol"},{"key":"10.1093\/ajcn\/75.4.616_bib303","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1023\/A:1005372730310","article-title":"Folate-responsive homocystinuria and megaloblastic anaemia in a female patient with functional methionine synthase deficiency cblE disease","volume":"20","author":"Fowler","year":"1997","journal-title":"J Inherit Metab Dis"},{"key":"10.1093\/ajcn\/75.4.616_bib304","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1023\/A:1005382627986","article-title":"Cobalamin E (cblE) disease: a severe neurological disorder with megaloblastic anaemia, homocystinuria and low serum methionine","volume":"20","author":"Steen","year":"1997","journal-title":"J Inherit Metab Dis"},{"key":"10.1093\/ajcn\/75.4.616_bib305","doi-asserted-by":"crossref","first-page":"9467","DOI":"10.1021\/bi00492a021","article-title":"Crystal structures of recombinant human dihydrofolate reductase complexed with folate and 5-deazafolate","volume":"29","author":"Davies","year":"1990","journal-title":"Biochemistry"},{"key":"10.1093\/ajcn\/75.4.616_bib306","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJM197503062921001","article-title":"Folate-responsive homocystinuria and \u201cschizophrenia.\u201d A defect in methylation due to deficient 5,10-methylenetetrahydrofolate reductase activity","volume":"292","author":"Freeman","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1093\/ajcn\/75.4.616_bib307","first-page":"242","article-title":"Folate-responsive homocystinuria and \u201cschizophrenia.\u201d","volume":"40","year":"1982","journal-title":"Nutr Rev"},{"key":"10.1093\/ajcn\/75.4.616_bib308","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF01811482","article-title":"Folic acid responsive rages, seizures and homocystinuria","volume":"8","author":"Murphy","year":"1985","journal-title":"J Inherit Metab Dis"},{"key":"10.1093\/ajcn\/75.4.616_bib309","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1016\/S0024-3205(00)00556-7","article-title":"Plasma homocysteine concentrations are positively associated with hostility and anger","volume":"66","author":"Stoney","year":"2000","journal-title":"Life Sci"},{"key":"10.1093\/ajcn\/75.4.616_bib310","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/(SICI)1096-8628(19970919)74:5<526::AID-AJMG14>3.0.CO;2-E","article-title":"Methylenetetrahydrofolate reductase variant and schizophrenia\/depression","volume":"74","author":"Arinami","year":"1997","journal-title":"Am J Med Genet"},{"key":"10.1093\/ajcn\/75.4.616_bib311","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/sj.mp.4000724","article-title":"Association between the methylenetetrahydrofolate reductase 677C\u2192T missense mutation and schizophrenia","volume":"5","author":"Joober","year":"2000","journal-title":"Mol Psychiatry"},{"key":"10.1093\/ajcn\/75.4.616_bib312","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF01271539","article-title":"Homocysteinemia is a common feature of schizophrenia","volume":"100","author":"Regland","year":"1995","journal-title":"J Neural Transm Gen Sect"},{"key":"10.1093\/ajcn\/75.4.616_bib313","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/BF01285561","article-title":"Homozygous thermolabile methylenetetrahydrofolate reductase in schizophrenia-like psychosis","volume":"104","author":"Regland","year":"1997","journal-title":"J Neural Transm"},{"key":"10.1093\/ajcn\/75.4.616_bib314","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0006-3223(97)00427-7","article-title":"Schizophrenia and impaired homocysteine metabolism: a possible association","volume":"44","author":"Susser","year":"1998","journal-title":"Biol Psychiatry"},{"key":"10.1093\/ajcn\/75.4.616_bib315","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/sj.mp.4000390","article-title":"C677T polymorphism in methylenetetrahydrofolate reductase gene and psychoses","volume":"3","author":"Kunugi","year":"1998","journal-title":"Mol Psychiatry"},{"key":"10.1093\/ajcn\/75.4.616_bib316","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1097\/00001756-199907130-00008","article-title":"Plasma homocysteine and the methylenetetrahydrofolate reductase C677T gene variant: lack of association with schizophrenia","volume":"10","author":"Virgos","year":"1999","journal-title":"Neuroreport"},{"key":"10.1093\/ajcn\/75.4.616_bib317","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1177\/153537020122600402","article-title":"Folate, homocysteine and neural tube defects: an overview","volume":"226","author":"van der Put","year":"2001","journal-title":"Exp Biol Med"},{"key":"10.1093\/ajcn\/75.4.616_bib318","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1620\/tjem.93.1","article-title":"Megaloblastic anemia and mental retardation associated with hyperfolic-acidemia: probably due to N5 methyltetrahydrofolate transferase deficiency","volume":"93","author":"Arakawa","year":"1967","journal-title":"Tohoku J Exp Med"},{"key":"10.1093\/ajcn\/75.4.616_bib319","first-page":"686","article-title":"Congenital megaloblastic anemia responsive to N5-formyl tetrahydrofolic acid administration","volume":"70","author":"Walters","year":"1967","journal-title":"J Pediatr"},{"key":"10.1093\/ajcn\/75.4.616_bib320","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0950-3536(05)80222-7","article-title":"Congenital errors of folate metabolism","volume":"8","author":"Zittoun","year":"1995","journal-title":"Baillieres Clin Haematol"},{"key":"10.1093\/ajcn\/75.4.616_bib321","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/0002-9343(70)90009-4","article-title":"Congenital defects in folate utilization","volume":"48","author":"Arakawa","year":"1970","journal-title":"Am J Med"},{"key":"10.1093\/ajcn\/75.4.616_bib322","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1056\/NEJM197510162931606","article-title":"Inborn errors of folate metabolism (second of two parts)","volume":"293","author":"Erbe","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1093\/ajcn\/75.4.616_bib323","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1203\/00006450-197503000-00001","article-title":"Metabolic studies of a family with massive formiminoglutamic aciduria","volume":"9","author":"Perry","year":"1975","journal-title":"Pediatr Res"},{"key":"10.1093\/ajcn\/75.4.616_bib324","series-title":"Folates and pterins.","first-page":"413","article-title":"Inborn errors of folate metabolism","author":"Erbe","year":"1986"},{"key":"10.1093\/ajcn\/75.4.616_bib325","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1182\/blood.V54.5.1080.1080","article-title":"Hereditary dyserythropoiesis with abnormal membrane folate transport","volume":"54","author":"Howe","year":"1979","journal-title":"Blood"},{"key":"10.1093\/ajcn\/75.4.616_bib326","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1177\/088307389901400809","article-title":"Folinic acid-responsive neonatal seizures","volume":"14","author":"Torres","year":"1999","journal-title":"J Child Neurol"},{"key":"10.1093\/ajcn\/75.4.616_bib327","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1093\/hmg\/9.19.2837","article-title":"Glutamate carboxypeptidase II: a polymorphism associated with lower levels of serum folate and hyperhomocysteinemia","volume":"9","author":"Devlin","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1093\/ajcn\/75.4.616_bib328","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1572-0241.2001.03474.x","article-title":"Effects of folate supplementation on two provisional molecular markers of colon cancer: a prospective, randomized trial","volume":"96","author":"Kim","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1093\/ajcn\/75.4.616_bib329","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1093\/jn\/131.10.2643","article-title":"Polymorphisms of key enzymes in homocysteine metabolism affect diet responsiveness of plasma homocysteine in healthy women","volume":"131","author":"Silaste","year":"2001","journal-title":"J Nutr"},{"key":"10.1093\/ajcn\/75.4.616_bib330","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/(SICI)1096-8652(200005)64:1<71::AID-AJH13>3.0.CO;2-Z","article-title":"Folate sufficient subjects do not accumulate additional folates during supplementation","volume":"64","author":"Santhosh-Kumar","year":"2000","journal-title":"Am J Hematol"},{"key":"10.1093\/ajcn\/75.4.616_bib331","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/(SICI)1096-8628(19961028)65:3<241::AID-AJMG13>3.0.CO;2-O","article-title":"Hereditary deficiency of vitamin K-dependent coagulation factors with skeletal abnormalities","volume":"65","author":"Boneh","year":"1996","journal-title":"Am J Med Genet"},{"key":"10.1093\/ajcn\/75.4.616_bib332","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1055\/s-0038-1657595","article-title":"Structure and mechanism of action of the vitamin K-dependent gamma-glutamyl carboxylase: recent advances from mutagenesis studies","volume":"78","author":"Furie","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1093\/ajcn\/75.4.616_bib333","doi-asserted-by":"crossref","first-page":"32572","DOI":"10.1074\/jbc.M006808200","article-title":"Expression and characterization of the naturally occurring mutation L394R in human gamma-glutamyl carboxylase","volume":"275","author":"Mutucumarana","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1093\/ajcn\/75.4.616_bib334","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1182\/blood.V96.10.3650","article-title":"Novel mutation in the gamma-glutamyl carboxylase gene resulting in congenital combined deficiency of all vitamin K-dependent blood coagulation factors","volume":"96","author":"Spronk","year":"2000","journal-title":"Blood"},{"key":"10.1093\/ajcn\/75.4.616_bib335","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1182\/blood.V53.4.776.776","article-title":"Congenital deficiency of blood clotting factors II, VII, IX, and X","volume":"53","author":"Chung","year":"1979","journal-title":"Blood"},{"key":"10.1093\/ajcn\/75.4.616_bib336","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1172\/JCI118956","article-title":"A mutation in the propeptide of factor IX leads to warfarin sensitivity by a novel mechanism","volume":"98","author":"Chu","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1093\/ajcn\/75.4.616_bib337","first-page":"686","article-title":"Vitamin K absorption capacity and its association with vitamin K deficiency","volume":"143","author":"Shinzawa","year":"1989","journal-title":"Am J Dis Child"},{"key":"10.1093\/ajcn\/75.4.616_bib338","series-title":"Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride.","year":"1997"},{"key":"10.1093\/ajcn\/75.4.616_bib339","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1172\/JCI116539","article-title":"Two mutations in the hormone binding domain of the vitamin D receptor cause tissue resistance to 1,25 dihydroxyvitamin D3","volume":"92","author":"Kristjansson","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1093\/ajcn\/75.4.616_bib340","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1172\/JCI119158","article-title":"Hereditary vitamin D resistant rickets caused by a novel mutation in the vitamin D receptor that results in decreased affinity for hormone and cellular hyporesponsiveness","volume":"99","author":"Malloy","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1093\/ajcn\/75.4.616_bib341","first-page":"1617","article-title":"Vitamin D receptors from patients with resistance to 1,25-dihydroxyvitamin D3: point mutations confer reduced transactivation in response to ligand and impaired interaction with the retinoid X receptor heterodimeric partner","volume":"10","author":"Whitfield","year":"1996","journal-title":"Mol Endocrinol"},{"key":"10.1093\/ajcn\/75.4.616_bib342","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1210\/jcem-63-1-252","article-title":"Severely deficient binding of 1,25-dihydroxyvitamin D to its receptors in a patient responsive to high doses of this hormone","volume":"63","author":"Castells","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1093\/ajcn\/75.4.616_bib343","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1023\/A:1011280518278","article-title":"Variants of the VDR gene and risk of colon cancer (United States)","volume":"12","author":"Slattery","year":"2001","journal-title":"Cancer Causes Control"},{"key":"10.1093\/ajcn\/75.4.616_bib344","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0960-0760(00)00141-2","article-title":"Vitamin D and prostate cancer","volume":"76","author":"Tuohimaa","year":"2001","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1093\/ajcn\/75.4.616_bib345","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0950-351X(05)80254-X","article-title":"Vitamin D resistance","volume":"8","author":"Hewison","year":"1994","journal-title":"Baillieres Clin Endocrinol Metab"},{"key":"10.1093\/ajcn\/75.4.616_bib346","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1086\/302156","article-title":"Genetics of vitamin D 1\u03b1-hydroxylase deficiency in 17 families","volume":"63","author":"Wang","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1093\/ajcn\/75.4.616_bib347","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/978-1-4615-4857-7_44","article-title":"Treatment of generalized morphea with oral 1,25-dihydroxyvitamin D3","volume":"455","author":"Caca-Biljanovska","year":"1999","journal-title":"Adv Exp Med Biol"},{"key":"10.1093\/ajcn\/75.4.616_bib348","series-title":"Dietary reference intakes for vitamin C, vitamin E, selenium, and carotenoids.","year":"2000"},{"key":"10.1093\/ajcn\/75.4.616_bib349","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1212\/WNL.55.10.1584","article-title":"Ataxia with vitamin E deficiency: biochemical effects of malcompliance with vitamin E therapy","volume":"55","author":"Schuelke","year":"2000","journal-title":"Neurology"},{"key":"10.1093\/ajcn\/75.4.616_bib350","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1046\/j.1468-1331.2001.00273.x","article-title":"Effect of vitamin E supplementation in patients with ataxia with vitamin E deficiency","volume":"8","author":"Gabsi","year":"2001","journal-title":"Eur J Neurol"},{"key":"10.1093\/ajcn\/75.4.616_bib351","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1023\/A:1010596317296","article-title":"Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency in Dutch neonates","volume":"24","author":"Spaapen","year":"2001","journal-title":"J Inherit Metab Dis"},{"key":"10.1093\/ajcn\/75.4.616_bib352","first-page":"47","article-title":"Treatment of mild phenylketonuria (PKU) by tetrahydrobiopterin (BH4)","volume":"23","author":"Trefz","year":"2000","journal-title":"J Inherit Metab Dis"},{"key":"10.1093\/ajcn\/75.4.616_bib353","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1006\/mgme.2000.2970","article-title":"The V388M mutation results in a kinetic variant form of phenylalanine hydroxylase","volume":"69","author":"Leandro","year":"2000","journal-title":"Mol Genet Metab"},{"key":"10.1093\/ajcn\/75.4.616_bib354","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1023\/A:1010371002631","article-title":"A structural hypothesis for BH4 responsiveness in patients with mild forms of hyperphenylalaninaemia and phenylketonuria","volume":"24","author":"Erlandsen","year":"2001","journal-title":"J Inherit Metab Dis"},{"key":"10.1093\/ajcn\/75.4.616_bib355","first-page":"45","article-title":"Tetrahydrobiopterin-responsive hyperphenylalaninemia (HPA) in Dutch neonates","volume":"23","author":"Spaapen","year":"2000","journal-title":"J Inherit Metab Dis"},{"key":"10.1093\/ajcn\/75.4.616_bib356","unstructured":"Scriver CR, Prevost L. Phenylalanine hydroxylase locus database. Internet: http:\/\/data.mch.mcgill.ca\/pahdb_new (accessed 3 February 2002)."},{"key":"10.1093\/ajcn\/75.4.616_bib357","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1212\/WNL.55.9.1407","article-title":"Brain creatine depletion: guanidinoacetate methyltransferase deficiency (improving with creatine supplementation)","volume":"55","author":"Leuzzi","year":"2000","journal-title":"Neurology"},{"key":"10.1093\/ajcn\/75.4.616_bib358","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1136\/hrt.72.4.349","article-title":"Dilated cardiomyopathy due to type II X-linked 3-methylglutaconic aciduria: successful treatment with pantothenic acid","volume":"72","author":"Ostman-Smith","year":"1994","journal-title":"Br Heart J"},{"key":"10.1093\/ajcn\/75.4.616_bib359","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0140-6736(05)64755-1","article-title":"Maternal 3-methylglutaconic aciduria associated with abnormalities in offspring","volume":"348","author":"de Koning","year":"1996","journal-title":"Lancet"},{"key":"10.1093\/ajcn\/75.4.616_bib360","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ng572","article-title":"A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome","volume":"28","author":"Zhou","year":"2001","journal-title":"Nat Genet"},{"key":"10.1093\/ajcn\/75.4.616_bib361","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0022-3476(84)80591-0","article-title":"Lipoamide dehydrogenase deficiency with primary lactic acidosis: favorable response to treatment with oral lipoic acid","volume":"104","author":"Matalon","year":"1984","journal-title":"J Pediatr"},{"key":"10.1093\/ajcn\/75.4.616_bib362","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1212\/WNL.28.12.1283","article-title":"Kinetic evidence for a structural abnormality of lipoamide dehydrogenase in two patients with Friedreich ataxia","volume":"28","author":"Rodriguez-Budelli","year":"1978","journal-title":"Neurology"},{"key":"10.1093\/ajcn\/75.4.616_bib363","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0925-4439(97)00073-2","article-title":"Deficiency of dihydrolipoamide dehydrogenase due to two mutant alleles (E340K and G101del). Analysis of a family and prenatal testing","volume":"1362","author":"Hong","year":"1997","journal-title":"Biochim Biophys Acta"},{"key":"10.1093\/ajcn\/75.4.616_bib364","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/BF00441554","article-title":"Neonatal pyruvate dehydrogenase deficiency with lipoate responsive lactic acidaemia and hyperammonaemia","volume":"148","author":"Byrd","year":"1989","journal-title":"Eur J Pediatr"},{"key":"10.1093\/ajcn\/75.4.616_bib365","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0022-3476(97)70157-4","article-title":"Mitochondrial carnitine-acylcarnitine translocase deficiency presenting as sudden neonatal death","volume":"131","author":"Chalmers","year":"1997","journal-title":"J Pediatr"},{"key":"10.1093\/ajcn\/75.4.616_bib366","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1006\/bbrc.1998.9679","article-title":"Carnitine uptake defect: frameshift mutations in the human plasmalemmal carnitine transporter gene","volume":"252","author":"Lamhonwah","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1093\/ajcn\/75.4.616_bib367","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1089\/thy.1997.7.775","article-title":"Clinical and hormonal outcome after two years of triiodothyroacetic acid treatment in a child with thyroid hormone resistance","volume":"7","author":"Radetti","year":"1997","journal-title":"Thyroid"},{"key":"10.1093\/ajcn\/75.4.616_bib368","first-page":"2033","article-title":"Triiodothyroacetic acid has unique potential for therapy of resistance to thyroid hormone","volume":"80","author":"Takeda","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1093\/ajcn\/75.4.616_bib369","first-page":"267","article-title":"Hormone-nuclear receptor interactions in health and disease. Thyroid hormone resistance","volume":"8","author":"Chatterjee","year":"1994","journal-title":"Baillieres Clin Endocrinol Metab"},{"key":"10.1093\/ajcn\/75.4.616_bib370","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1089\/thy.1997.7.771","article-title":"A novel point mutation of thyroid hormone receptor beta gene in a family with resistance to thyroid hormone","volume":"7","author":"Nagashima","year":"1997","journal-title":"Thyroid"},{"key":"10.1093\/ajcn\/75.4.616_bib371","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1600-0404.1995.tb00438.x","article-title":"Decreased plasma alanine and isoleucine in Huntington\u2019s disease","volume":"91","author":"Reilmann","year":"1995","journal-title":"Acta Neurol Scand"},{"key":"10.1093\/ajcn\/75.4.616_bib372","doi-asserted-by":"crossref","first-page":"12240","DOI":"10.1073\/pnas.93.22.12240","article-title":"Mutations in copper-zinc superoxide dismutase that cause amyotrophic lateral sclerosis alter the zinc binding site and the redox behavior of the protein","volume":"93","author":"Lyons","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1093\/ajcn\/75.4.616_bib373","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1074\/jbc.275.2.1007","article-title":"Loss of in vitro metal ion binding specificity in mutant copper-zinc superoxide dismutases associated with familial amyotrophic lateral sclerosis","volume":"275","author":"Goto","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1093\/ajcn\/75.4.616_bib374","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1046\/j.1471-4159.1997.69051936.x","article-title":"Decreased zinc affinity of amyotrophic lateral sclerosis-associated superoxide dismutase mutants leads to enhanced catalysis of tyrosine nitration by peroxynitrite","volume":"69","author":"Crow","year":"1997","journal-title":"J Neurochem"},{"key":"10.1093\/ajcn\/75.4.616_bib375","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1126\/science.286.5449.2498","article-title":"Induction of nitric oxide-dependent apoptosis in motor neurons by zinc-deficient superoxide dismutase","volume":"286","author":"Estevez","year":"1999","journal-title":"Science"},{"key":"10.1093\/ajcn\/75.4.616_bib376","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1073\/pnas.96.7.3922","article-title":"Constitutive and regulated alpha-secretase cleavage of Alzheimer\u2019s amyloid precursor protein by a disintegrin metalloprotease","volume":"96","author":"Lammich","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1093\/ajcn\/75.4.616_bib377","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1006\/abbi.1999.1644","article-title":"Monovalent cation activation in Escherichia coli inosine 5\u2032-monophosphate dehydrogenase","volume":"375","author":"Kerr","year":"2000","journal-title":"Arch Biochem Biophys"}],"container-title":["The American Journal of Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002916523061701?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002916523061701?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/ajcn\/article-pdf\/75\/4\/616\/23657738\/616.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:27:43Z","timestamp":1751243263000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002916523061701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,4]]},"references-count":377,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002,4]]}},"alternative-id":["S0002916523061701"],"URL":"https:\/\/doi.org\/10.1093\/ajcn\/75.4.616","relation":{},"ISSN":["0002-9165"],"issn-type":[{"value":"0002-9165","type":"print"}],"subject":[],"published":{"date-parts":[[2002,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-dose vitamin therapy stimulates variant enzymes with decreased coenzyme binding affinity (increased Km): relevance to genetic disease and polymorphisms","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1093\/ajcn\/75.4.616","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2002 American Society for Nutrition. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}